acetylcysteine has been researched along with Acute Kidney Failure in 292 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.03) | 18.7374 |
| 1990's | 11 (3.77) | 18.2507 |
| 2000's | 114 (39.04) | 29.6817 |
| 2010's | 134 (45.89) | 24.3611 |
| 2020's | 30 (10.27) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, FT; Drew, RC; Fernandes, SM; Fonseca, CD; Pessoa, EA; Vattimo, MFF; Volpini, RA; Watanabe, M | 1 |
| Wang, Y; Weng, J; Ye, D; Zhang, Y | 1 |
| Kang, GS; Kofidis, T; Luo, H; Tan, YK; Teoh, KL | 1 |
| Bhargava, M; Bhargava, V; Brar, JE; Kaushal, R; Khullar, D; Singh, K | 1 |
| El Hussein, MT; Ha, C | 1 |
| Huang, P; Lei, S; Lin, J; Liu, H; Qu, J; Tu, T; Younis, MR; Zhang, DY; Zhu, KS | 1 |
| Clark, EG; Davis, A; Hiremath, S; Ilin, JV; Kong, JWY; Magner, K | 1 |
| Boskabadi, J; Salehifar, E; Yousefi-Mazhin, E | 1 |
| McDonald, JS | 1 |
| Haar, I; Strehle, EM | 1 |
| Ateş, ÖF; Danışan, G; Eren, F; Erkin, A; Küpeli, A; Neşelioğlu, S; Öğüşlü, U; Özdemir, M; Taydaş, O | 1 |
| Abdulazim, DO; Amin, M; Csongradi, E; ElAzim, IMA; Elhadidy, S; Fayed, A; Hammad, AA; Hammad, H; Salem, MM; Sharaf El Din, UA; Soliman, KM; Zsom, L | 1 |
| Bacaicoa, MC; Erviti, J; Gómez, H; Gutiérrez-Valencia, M; Leache, L; Maestro, C; Saiz, LC | 1 |
| Davidopoulou, S; Kalogirou, TE; Meditskou, S; Pitoulias, AG; Pitoulias, GA; Savvas, I | 1 |
| Kaufman, JS; Liu, C; Mor, MK; Palevsky, PM; Parikh, CR; Thiessen Philbrook, H; Weisbord, SD | 1 |
| Dağli, F; Güntürk, I; Köse, SK; Yay, AH; Yazici, C; Yücel, B | 1 |
| Hiremath, S; Velez, JCQ | 1 |
| Khajeh Dalooee, M; Moosavi Nik, S; Naghibi, M; Raeesi, V; Samadi, K; Samadi, M; Shabestari, M; Sharifipour, F | 1 |
| Amin, A; Barón, AE; Gilmartin, HM; Keach, JW; Langner, P; Maddox, TM; Plomondon, ME; Stanislawski, MA; Waldo, S | 1 |
| Fan, H; Le, JW; Zhu, JH | 1 |
| Aggarwal, D; Gurm, HS | 1 |
| Badri, S; Khorvash, F; Meidani, M; Sayadi, M; Soltani, R; Taheri, S | 1 |
| Gholamrezanezhad, A; Joyce, P; Salehi, S; Shin, H; Taghavifar, S | 1 |
| Liang, X; Lin, Z; Ling, Z; Liu, M; Xie, W | 1 |
| Akgun, E; Boyacioglu, M; Kum, S | 1 |
| Chen, JY; Chen, S; Guo, Z; Huang, H; Lei, L; Lin, Y; Liu, J; Liu, L; Liu, Y; Tao, J; Wu, K; Xu, Q; Xue, Y; Zhang, L | 1 |
| Amma, BSPT; Balakrishnan, D; Bharathan, VK; Chandran, B; Gopalakrishnan, U; Mallick, S; Mathew, JS; Menon, RN; Nair, K; Sudheer, OV; Surendran, S; Thirunavayakalathil, MA; Varghese, CT | 1 |
| Alcock, E; Bhan, A; Dew, T; Dworakowski, R; MacCarthy, P; Monaghan, M; Navaratnarajah, A; Shah, AM; Wendler, O | 1 |
| Alshogran, OY; Alzoubi, KH; El-Elimat, T; Nusair, SD; Obeidat, A; Sweidan, M | 1 |
| Dahal, UP; David, B; Davies, R; Humphreys, WG; Ishida, K; Jiang, M; Lipford, JR; Monticello, TM; Siska, W; Stauber, J; Thomas, B; Wahlstrom, J; Werner, JA | 1 |
| Akhondzadeh, R; Hayati, F; Javaherforooshzadeh, F; Rashidi, M; Shaker, Z | 1 |
| Dou, Q; Gan, H; Tong, H; Yang, Y; Zhang, H | 1 |
| Adedoyin, O; Agarwal, A; Boddu, R; Bolisetty, S; George, JF; Lever, JM; Traylor, A | 1 |
| Manskikh, VN; Pavlenko, TA; Pevzner, IB; Plotnikov, EY; Silachev, DN; Sukhikh, GT; Zorov, DB; Zorova, LD | 1 |
| Garoufalis, G; Makris, D; Palli, E; Papanikolaou, J; Tsilioni, I; Zakynthinos, E; Zygoulis, P | 1 |
| Androsenko, M; Bhatt, DL; Brophy, M; Cass, A; Chertow, GM; Conner, TA; Ferguson, R; Gallagher, M; Garcia, S; Jneid, H; Kaufman, J; McFalls, EO; Myles, J; Palevsky, PM; Parikh, CR; Shunk, K; Thwin, SS; Weisbord, SD; Wu, H | 1 |
| Huynh, K | 1 |
| Solomon, R | 3 |
| Brooks, HL; Coombes, JS; Gobe, GC; Johnson, DW; Morais, C; Roy, SF; Sanchez, WY; Small, DM | 1 |
| Han, XQ; Liu, NF; Ma, WQ; Wang, Y; Zhao, Y; Zhu, Y | 1 |
| Gao, J; Gu, Z; Liang, B; Xu, Y; Zheng, X | 1 |
| Chaibakhsh, S; Einollahi, B; Modarresi, A; Nafar, M; Panahi, Y; Parvin, M; Sahraei, Z; Salamzadeh, J; Ziaie, S | 1 |
| Chen, C; Gu, Y; Hei, Z; Huang, F; Wang, Y; Wu, S; Yuan, D; Zhou, S | 1 |
| Kang, PS; Partovi, S; Trischman, T | 1 |
| Dalili, N; Mahmoudieh, L; Samadian, F; Ziaei, S | 1 |
| Aslan, T; Ceylan, B; Ercan, Ç; Kılıç, Ü; Ozansoy, M; Yıldız, P; Yozgat, Y | 1 |
| Alhusaini, AM; El Orabi, NF; Faddah, LM; Hasan, IH | 1 |
| Müller, GA; Patschan, D | 1 |
| Dalugama, C; Gawarammana, IB | 1 |
| Brewster, DJ; Horrigan, D; Sarode, V; Tan, SI | 1 |
| Aparicio-Trejo, OE; Briones-Herrera, A; Hernández-Pando, R; León-Contreras, JC; Pedraza-Chaverri, J; Reyes-Fermín, LM; Sánchez-Lozada, LG; Tapia, E | 1 |
| Hou, FF; Li, C; Li, Y; Liu, C; Wang, J; Xie, N | 1 |
| Bayat, Z; Kadioglu, E; Ozatik, FY; Ozatik, O; Teksen, Y | 1 |
| He, G; Li, Q; Li, W; Wang, L; Yang, J; Zeng, F | 1 |
| Baldwin, GS; Bolton, DM; Ischia, JJ; O'Kane, D; Patel, O | 1 |
| Kaluski, E; Khan, MS; Khan, MU; Khan, SU; Novak, M; Opoku-Asare, I; Rahman, H; Riaz, H | 1 |
| Snyder, CJ; Westerfield, KL; Will, JS | 1 |
| Huang, S; Li, Y; Liang, X; Liu, Y; Wang, K; Wei, H; You, J; Zhang, Y | 1 |
| Furukawa, LNS; Pereira, RC; Romão, CM; Shimizu, MHM | 1 |
| Fischereder, M; Kazmierczak, P; Ricke, J; Weidenbusch, M; Wörnle, M | 1 |
| Heidarian, E; Nouri, A | 1 |
| Alessandri, N; Di Matteo, A; Garante, CM; Lanzi, L; Petrassi, M; Sergiacomi, R; Tersigni, F; Tufano, F | 1 |
| Agilli, M; Alp, BF; Aydin, FN; Aydin, I; Cayci, T; Macit, E; Ozcan, A; Ozkan, E; Oztosun, M; Taslipinar, MY; Toygar, M; Ucar, F | 1 |
| Bergo, RR; Berwanger, O; Buehler, A; Cantarelli, MJ; Carvalho, VO; Castello-Júnior, HJ; Cavalcanti, AB; da Motta, PA; Kodama, A; Mangione, JA; Nunes, PM; São Thiago, LE; Sousa, AM; Sousa, JE; Victor, E | 1 |
| Brodsky, SV; Hebert, LA; Nadasdy, G; Nadasdy, T; Ozcan, A; Qamri, Z; Rovin, BH; Satoskar, AA; Ware, K | 1 |
| Agilli, M; Alp, BF; Altayli, E; Aydin, FN; Aydin, I; Cayci, T; Cermik, H; Ozkan, E; Taslipinar, MY; Toygar, M; Ucar, F | 1 |
| Brophy, MT; Cass, A; Chertow, GM; Conner, TA; Fine, MJ; Gallagher, M; Huang, GD; Kaufman, J; Lee, J; Lew, RA; McCullough, PA; Mor, MK; Palevsky, PM; Parikh, CR; Shunk, KA; Soliva, S; Weisbord, SD | 1 |
| Amathieu, R; Chemit, M; Compagnon, P; Costentin, C; Dhonneur, G; Levesque, E; Merle, JC | 1 |
| Becker, CD; De Seigneux, S; Dupuis-Lozeron, E; Martin, PY; Perneger, T; Platon, A; Poletti, PA; Sarasin, F; Saudan, P | 1 |
| Boedeker, RH; Boening, A; Brueck, M; Cengiz, H; Hoeltgen, R; Scheibelhut, C; Wieczorek, M | 1 |
| Aresmouk, D; Berndt, S; Grebe, SO; Herget-Rosenthal, S; Langenbeck, M; Schaper, A | 1 |
| Briguori, C; Condorelli, G; Donnarumma, E; Fiore, D; Quintavalle, C | 2 |
| Sadat, U | 1 |
| Bortolotto, LA; De Lima, JJ; Drager, LF; Gaiotto, FA; Gowdak, LH; Hajjar, LA; Puig, LB; Santana-Santos, E; Shimizu, MH; Zeferino, SP | 1 |
| Akcay, S; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, T; Uysal, BA; Varol, E; Yucel, H | 1 |
| Chang, SS; Chang, SW; Chen, CH; Huang, CC; Lam, CF; Su, MW; Tsai, YC | 1 |
| Amini, E; Ashouri, A; Ataei, S; Ghavamzadeh, A; Gholami, K; Hadjibabaie, M; Hayatshahi, A; Moslehi, A; Taghizadeh-Ghehi, M; Vaezi, M | 1 |
| Dong, G; Dong, Z; Huo, Y; Ma, Z; Wei, Q | 1 |
| Hu, Z; Liu, J; Zhang, L; Zhu, Z | 1 |
| Jhaveri, KD; Khan, S; Kolitz, JE; Wanchoo, R | 1 |
| Franklin, T; Li, LP; Lu, J; Papadopoulou, MV; Prasad, PV; Solomon, R; Thacker, J; Zhou, Y | 1 |
| Fu, J; Ji, K; Li, G; Luan, T; Zang, B; Zhao, Y | 1 |
| Abramowitz, Y; Arbel, Y; Banai, S; Ben-Assa, E; Finkelstein, A; Halkin, A; Havakuk, O; Keren, G; Konigstein, M; Leshem-Rubinow, E; Schwartz, AL; Steinvil, A | 1 |
| Deniz, S; Haholu, A; Inangil, G; Muftuoglu, T; Ozkan, S; Sen, H; Yedekci, AE | 1 |
| Caixeta, A; Inda-Filho, AJ; Manggini, M; Schor, N | 1 |
| Jang, J; Kwak, YL; Shim, JK; Soh, S; Song, JW | 1 |
| Dong, Z; Guo, C; Su, Y; Wei, Q | 1 |
| Chen, W; Liang, C; Liang, L; Zhang, B; Zhang, S | 1 |
| Atar, S; Eizenberg, S; Feldman-Idov, Y; Kristal, B; Marzuq, N; Ofir, P; Shema-Didi, L; Sussan, M | 1 |
| Heidari, R; Najibi, A; Niknahad, H; Rahimi, HR; Shirazi Yeganeh, B; Taheri, V | 1 |
| Hernandez, SH; Hoffman, RS; Howland, M; Schiano, TD | 1 |
| Askenazi, D; Cerda, J; de Caestecker, M; Faubel, S; Fissell, WH; Harrell, FE; Humphreys, BD; Liu, KD; Mour, G; Nolin, TD; Okusa, MD; Pullen, N | 1 |
| Chaudru, S; Jaquinandi, V; Kaladji, A; Koch, C; Lederlin, M; Mahé, G | 1 |
| Chin, CT; Lim, SL; Ng, CY; Tan, CS; Tan, PH; Woo, KT; Zhu, L | 1 |
| Brooks, CH; Chopra, TA; Okusa, MD | 1 |
| Ababneh, M; Altarabsheh, SE; Alzoubi, KH; De Caro, J; Deo, SV; Markowitz, AH; McConnell, BK; Park, SJ; Rababa'h, AM; Tarboush, NA | 1 |
| Kumar, S; Phan, K; Qian, P; Wang, N; Yan, TD | 1 |
| Cao, F; Chen, Y; Qian, G; Su, H | 1 |
| Ahn, Y; Cho, JG; Cho, JY; Choi, JS; Hong, YJ; Jeong, MH; Kang, JC; Kim, IS; Kim, JH; Kim, MC; Park, HW; Park, IH; Park, JC; Park, SH; Rhee, JA; Sim, DS | 1 |
| Mahadevan, S; Rameshkumar, R; Sharma, S | 1 |
| Irigoyen, MC; Koike, MK; Martins, JL; Montero, EF; Moreira, MA; Saad, KR; Saad, PF | 1 |
| Ali- Hasan- Al- Saegh, S; Dehghan, AM; Ghanei, A; Ghodratipour, Z; Haddad, F; Karimi-Bondarabadi, AA; Lotfaliani, M; Mahdavi, P; Mirhosseini, SJ; Popov, AF; Rahimizadeh, E; Sabashnikov, A; Sarrafan-Chaharsoughi, Z; Shahidzadeh, A; Tahernejad, M; Weymann, A; Zeriouh, M | 1 |
| Qi, GX; Tian, W; Zhao, SJ; Zhong, ZS | 1 |
| Rice, TW; Stollings, JL; Wheeler, AP | 1 |
| Chalikias, G; Drosos, I; Tziakas, DN | 1 |
| Dal-Pizzol, F; Damasio, DC; Fraga, CM; Ritter, C; Tomasi, CD; Vuolo, F | 1 |
| Canale, D; Froeder, L; Gois, PH; Heilberg, IP; Luchi, WM; Seguro, AC; Shimizu, MH; Volpini, RA | 1 |
| Mei, M; Pan, QG; Pu, YM; Shen, BB; Tang, MZ; Zhao, HW | 1 |
| Duan, Y; Gong, X; Hei, TK; Norgren, S; Wang, G; Wang, Y; Zheng, J | 1 |
| Chung, RT; Davern, T; Davis, BC; Fontana, RJ; Lee, WM; McGuire, B; Reddy, R; Stravitz, RT; Tillman, H | 1 |
| Alexandropoulos, D; Arkadopoulos, N; Bazigos, GV; Doulamis, IP; Kondi-Pafiti, A; Konstantopoulos, P; Kotsis, T; Perrea, DN; Smyrniotis, V; Tragotsalou, N; Tzani, A | 1 |
| Adabag, AS; Bloomfield, HE; Chandrashekhar, Y; Ishani, A; Johnson, DJ; Kelly, RF; Koneswaran, S; McFalls, EO; Ward, HB | 1 |
| Akaydin, Y; Duru, M; Helvaci, MR; Koç, A; Kuvandik, G; Nacar, A; Oksüz, H; Söğüt, S; Yönden, Z | 1 |
| Ho, KM; Morgan, DJ | 1 |
| Brincat, S; Hilton, R | 1 |
| Kandula, P; Nigwekar, SU | 1 |
| Al-Husseini, I; Al-Salam, S; Ali, BH; Nemmar, A | 1 |
| Fine, MJ; Hartwig, KC; Kim, S; Mor, MK; Palevsky, PM; Sonel, AF; Weisbord, SD | 1 |
| Gay, SB; Goldfarb, S; McCullough, PA; McDermott, J | 1 |
| Constantino, L; Dal-Pizzol, F; de Souza, B; Fraga, CM; Martins, MR; Petronilho, F; Reinke, A; Ritter, C | 1 |
| Hörl, WH | 1 |
| Adabag, AS; Bloomfield, HE; Ishani, A; Ngo, AK; Wilt, TJ | 1 |
| Crow, MT; Grigoryev, DN; Haas, M; Liu, M; Rabb, H; Reddy, SP; Yamamoto, M | 1 |
| Kellum, JA; Leblanc, M; Venkataraman, R | 1 |
| Kolh, P | 1 |
| Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Limbruno, U; Picchi, A; Pierli, C | 1 |
| Block, CA; Brown, JR; Malenka, DJ; O'Connor, GT; Schoolwerth, AC; Thompson, CA | 1 |
| Dauerman, HL | 1 |
| Amato, M; Bellandi, F; Gallopin, M; Leoncini, M; Maioli, M; Manzone, C; Micheletti, C; Tedeschi, D; Toso, A | 1 |
| Dai, F; Damian, D; Hilmi, IA; Kagan, VE; Kellum, JA; Peng, Z; Planinsic, RM; Tyurina, YY | 1 |
| Heyman, SN; Idée, JM; Khamaisi, M; Rosen, S; Rosenberger, C | 1 |
| Alemdar, R; Aydin, M; Basar, C; Caglar, O; Erden, I; Ordu, S; Ozhan, H; Yalcin, S | 1 |
| Brown, JR; Mautone, A | 1 |
| Adams, V; Desch, S; Diederich, KW; Eitel, I; Erbs, S; Fuernau, G; Gutberlet, M; Hildebrand, L; Linke, A; Nowak, M; Schirdewahn, C; Schuler, G; Thiele, H | 1 |
| Brar, S; Dangas, G; Mehran, R | 1 |
| Ashworth, A; Webb, ST | 1 |
| Brown, JR; Thompson, CA | 1 |
| Aksoy, N; Bas, M; Buyukhatipoglu, H; Kirhan, I; Sezen, Y; Taskin, A; Turan, MN; Ulas, T; Yildiz, A | 1 |
| Erbaş, M; Erkan, ME; Gezer, S; Güneş, H; Kandiş, H; Kara, IH; Yildirim, HA; Yildirim, U | 1 |
| Briguori, C; Condorelli, G; De Micco, F; Quintavalle, C | 1 |
| Marenzi, G; Sisillo, E | 1 |
| Aleksa, K; Bajcetic, M; Baw, B; Chen, N; Cutler, M; Freeman, D; Hanly, LN; Koren, G; Malkin, B; Palassery, R; Regueira, O; Rieder, MJ; Turner, C; Vasylyeva, TL | 1 |
| Bianchi, R; Bigazzi, MC; Calabrò, P; Calabrò, R; Caprile, M; Crisci, M; De Vita, A; Golia, E; Limongelli, G; Palmieri, R; Romano, IJ; Russo, MG | 1 |
| Deshpande, S; Patel Manali, B; Shah, G | 1 |
| Cattano, D | 1 |
| Kellum, JA; Murugan, R; Unruh, ML | 1 |
| Ahmed, HH; Assaf, N; Shalby, AB | 1 |
| Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G | 1 |
| Arinsoy, T; Bali, M; Demirtas, C; Derici, UB; Ebinc, FA; Erten, Y; Guz, G; Koc, E; Omeroglu, S; Pasaoglu, H; Reis, KA; Sindel, S | 1 |
| Ahsan, SA; Arzu, J; Awal, A; Banerjee, S; Hasan, MI; Siddique, MA; Subedi, B; Zaman, SM | 1 |
| Akgul, OE; Cakir, E; Cayci, T; Kizilgun, M; Kunak, ZI; Kurt, YG; Macit, E; Ozcan, A; Ozkan, E; Oztas, Y; Poyrazoglu, Y; Taslipinar, MY; Turker, T; Yaman, H; Yaren, H | 1 |
| Bishop, JV; Kellum, JA; Peng, ZY; Rimmelé, T; Wang, HZ; Wen, XY | 1 |
| Poli de Figueiredo, LF; Seguro, AC; Shimizu, MH | 1 |
| Airoldi, F; Briguori, C; Condorelli, G; Focaccio, A; Golia, B; Ricciardelli, B; Sangiorgi, GM; Valgimigli, M; Visconti, G | 1 |
| Jazrawi, A; Khambatta, S; McCullough, PA | 1 |
| Mullins, ME; Vitkovitsky, IV | 1 |
| Shebrain, S | 1 |
| Rachoin, JS | 1 |
| Biff, D; Dal-Pizzol, F; Felisberto, F; Fraga, CM; Petronilho, F; Ritter, C; Tomasi, CD; Topanotti, MF; Vuolo, F | 1 |
| Andrade, L; Campos, R; Canale, D; de Bragança, AC; Lopes, FD; Olivo, C; Seguro, AC; Shimizu, MH; Volpini, RA | 1 |
| Grahn, H; Kuck, KH; Spangenberg, T; van der Schalk, H | 1 |
| Delavari, F; Kadkhodaee, M; Mikaeili, S; Ostad, SN; Seifi, B; Shams, S | 1 |
| Carlsson, K; Celsi, G; Gong, X; Norgren, S | 1 |
| Binder, C; Jaberi, A; Kitzler, TM; Kotanko, P; Petnehazy, E; Rehak, P; Sendlhofer, G; Stacher, R | 1 |
| Jo, YH; Kim, K; Kwon, WY; Lee, JH; Rhee, JE; Rim, KP; Suh, GJ | 1 |
| Jahanshahi, A; Jahanshahi, G; Khansari, M; Sotoudeh, A; Takhtfooladi, HA; Takhtfooladi, MA | 1 |
| Eisenhut, M | 1 |
| De Capadocia Rosell, J; Jiménez Vizuete, JM; Lozano Serrano, B; Mateo Cerdá, CM | 1 |
| Alamri, H; Albabtain, MA; Almasood, A; Alshurafah, H; Tamim, H | 1 |
| Braden, GL; Freda, BJ; Hariharan, MV; Sivalingam, SK | 1 |
| Albarracín, LM; Bernasconi, AR; Heguilén, RM; Liste, AA; Ortemberg, MG; Payaslian, M | 1 |
| Bianco, A; Briguori, C; Colombo, A; Condorelli, G; De Micco, F; Donnarumma, E; Fiore, D; Focaccio, A; Golia, B; Quintavalle, C; Ricciardelli, B; Troncone, G; Visconti, G; Zabatta, MA | 1 |
| Grace, PA; Healy, DA; Moloney, MC; O'Sullivan, S; Walsh, SR | 1 |
| Busch, SV; Gögenur, I; Jensen, SE; Rosenberg, J | 1 |
| Bai, CH; Hsiang, CY; Hsiang, HF; Hsu, YH; Li, YW; Lin, YF; Tam, KW; Wong, CS; Wu, MY; Yao, MS | 1 |
| El-Desoky, KI; El-Sisi, Ael-D; El-Syaad, ME; Moussa, EA | 1 |
| Brophy, DF | 1 |
| Feinfeld, DA; Nisar, S | 1 |
| Justo, P; Marrón, B; Ortiz, A; Sanz, A | 1 |
| Caputo, C; Dokko, J; Durham, JD; Dutka, P; Fishbane, S; Keltz, J; Maesaka, JK; Marzo, K; Pahlavan, M; Zaharakis, T | 1 |
| Broseta, L; Fernández-Fúnez, A; Polo, FJ; Valer, J; Zafrilla, L | 1 |
| Amhad, M; Boccalandro, F; Sdringola, S; Smalling, RW | 1 |
| Dean, LS | 1 |
| Goldfarb, M; Heyman, SN; Karmeli, F; Rosen, S; Shina, A | 1 |
| Emch, TM; Haller, NA | 1 |
| Akinwande, AO; Blankenship, JA; Campbell, B; Mouhayar, EN; Tadros, GM; Wood, C | 1 |
| Kellum, JA; Venkataraman, R | 3 |
| Kellum, JA | 1 |
| Birck, R; Braun, C; Krzossok, S; Markowetz, F; Schnülle, P; van der Woude, FJ | 1 |
| Howe, AM; Macon, EJ; Raven, QL; Walton, T | 1 |
| Bazari, H; Colon-Hernadez, P; DeJoseph, D; Harding, SA; Jang, IK; MacNeill, BD; Patton, KK | 1 |
| De Vriese, AS; Lameire, NH; Vanholder, R | 1 |
| Isenbarger, DW; Kent, SM; O'Malley, PG | 1 |
| Alonso, A; Jaber, BL; Lau, J; Sarnak, MJ; Weintraub, A | 1 |
| Adam, M; Agranat, O; Elian, D; Goldenberg, I; Guetta, V; Jonas, M; Matetzky, S; Pres, H; Schwammenthal, E; Shechter, M | 1 |
| Meine, TJ; Washam, JB | 1 |
| Angstwurm, MW; Sitter, T; Wörnle, M | 1 |
| Benz, M; Rezkalla, SH | 1 |
| Chan, AK; Chan, JY; Chan, WW; Fung, JW; Kum, LC; Sanderson, JE; Szeto, CC; Wong, JT; Woo, KS; Wu, EB; Yip, GW; Yu, CM | 1 |
| Asif, A; Epstein, M | 1 |
| Deray, G | 1 |
| Batisse, JP; Beygui, F; El Mahmoud, R; Helft, G; Le Feuvre, C; Le Quan Sang, KH; Metzger, JP | 1 |
| Faddy, SC | 1 |
| Koller, H; Rosenkranz, AR | 1 |
| Agarwal, R; Chebrolu, S; Leehey, DJ; Palubiak, DJ | 1 |
| Kellum, J; Leblanc, M; Venkataraman, R | 3 |
| Gowda, RM; Khan, IA; Leibowitz, K; Misra, D; Shapiro, M | 1 |
| Atienza, MP; Broseta Viana, L; Fernández-Fúnez, A; Polo-Romero, FJ; Sánchez Gascón, F | 1 |
| Bartorelli, AL; Marenzi, G | 1 |
| Agarwal, S; Baker, DM; Hamilton, G; Myint, F; Rashid, ST; Salman, M; Sweny, P | 1 |
| Mueller, C | 1 |
| Venkataraman, R | 2 |
| Duong, MH; MacKenzie, TA; Malenka, DJ | 1 |
| Bates, CM; Lin, F | 1 |
| Itoh, Y; Oishi, R; Sendo, T; Yano, T | 1 |
| Caraccio, T; Feinfeld, DA; McGuigan, M; Mour, G | 1 |
| Fischer, UM; Mehlhorn, U; Tossios, P | 1 |
| Andrade, L; Coimbra, TM; de Araujo, M; Rodrigues, AC; Seguro, AC | 1 |
| Oudemans-van Straaten, HM | 1 |
| Airoldi, F; Briguori, C; Carlino, M; Colombo, A; Condorelli, G; Focaccio, A; Montorfano, M; Morici, N; Ricciardelli, B; Sangiorgi, GM; Violante, A | 1 |
| Needham, E | 1 |
| Kolarz, M; Sułowicz, W | 1 |
| Basu, S; Guron, G; Haraldsson, B; Marcussen, N; Nilsson, U; Nitescu, N; Ricksten, SE | 1 |
| Bagshaw, SM; Ghali, WA; Manns, BJ; McAlister, FA | 1 |
| Akan, P; Camsari, T; Celik, A; Ormen, M; Sarioglu, S; Yenicerioglu, Y; Yilmaz, O | 1 |
| Chilakapati, J; Korrapati, MC; Latendresse, JR; Lock, EA; Mehendale, HM; Warbritton, A | 1 |
| Abdulkader, R; Castro, I; Macedo, E; Sobrinho, AC; Vieira, JM; Yu, L | 1 |
| Koike, K; Okuda, S | 1 |
| Dnyanmote, AV; Latendresse, JR; Lock, EA; Mehendale, HM; Sawant, SP; Warbritton, AA | 1 |
| Briguori, C; Marenzi, G | 1 |
| Hynninen, MS; Lepäntalo, MJ; Niemi, TT; Pöyhiä, R; Railo, MJ; Raininko, EI; Salmenperä, MT; Tallgren, MK | 1 |
| Assanelli, E; Bartorelli, AL; Campodonico, J; De Metrio, M; Fabbiocchi, F; Galli, S; Grazi, M; Lauri, G; Marana, I; Marenzi, G; Montorsi, P; Veglia, F | 1 |
| Krizova, B; Sochman, J | 1 |
| Abitbol, C; Berho, ME; Chandar, J; Espinoza, V; Onder, AM; Zilleruelo, G | 1 |
| Kuitunen, A; Kuitunen, T; Pöyhiä, R; Ristikankare, A; Salmenperä, M; Suojaranta-Ylinen, R; Uotila, L; Vento, A | 1 |
| Balderramo, DC | 1 |
| Boyle, JR; Firth, JD; Gaunt, ME; Lapsley, M; Moore, NN; Norden, AG; Varty, K | 1 |
| Becke, B; Breithardt, G; Fleiter, J; Fobker, M; Heitmeyer, C; Hense, HW; Reinecke, H; Schaefer, RM; Wellmann, J | 1 |
| Gilkey, GM; Komisarof, JA; Koudelka, CW; Meyer, MM; Peters, DM; Smith, SM | 1 |
| Shehabi, Y | 1 |
| Weisberg, LS | 1 |
| Scheller, B | 1 |
| Dong, G; Jing, H; Luo, L; Shao, H; Yin, R; Zhu, J | 1 |
| Bagshaw, SM; Bellomo, R; Buxton, B; Doolan, L; Haase, M; Haase-Fielitz, A; Matalanis, G; Morgera, S; Reade, MC; Seevenayagam, S | 1 |
| Filep, JG | 1 |
| Barrett, B; Benko, A; Capusten, B; Fraser-Hill, M; Magner, P; Myers, A; Owen, RJ | 1 |
| Schultz, MJ | 1 |
| De Vriese, AS; Van Praet, JT | 1 |
| Flynn, F; Georghiou, M; Jaggar, S; Morgan, PG | 1 |
| Brunkwall, J; Gawenda, M; Möller, A; Wassmer, G | 1 |
| Chen, SL; Chu, J; Kwan, TW; Lin, S; Liu, Z; Yan, J; Yei, F; Zhang, J; Zhang, R; Zhu, Z | 1 |
| Becker, CD; Martin, PY; Mermillod, B; Platon, A; Poletti, PA; Sarasin, FP; Saudan, P; Sautter, AM; Vermeulen, B | 1 |
| Kohtz, C; Thompson, M | 1 |
| Erley, C | 1 |
| Balkin, J; Lachish, T; Lifschitz, M; Rosenmann, D; Shavit, L; Slotki, I | 1 |
| Dangas, G; Mehran, R; Pucelikova, T | 1 |
| Fishbane, S | 1 |
| Bortone, F; Ceriani, R; Fiorentini, C; Juliano, G; Marenzi, G; Salvi, L; Sisillo, E; Veglia, F | 1 |
| Bouman, CC; Schultz, MJ | 1 |
| McCullough, PA | 1 |
| Bernstein, SJ; Carlos, RC; Cronin, P; Dwamena, B; Kelly, AM | 1 |
| Bouman, CS; Royakkers, AA; Schultz, MJ | 1 |
| Fujigaki, Y; Hishida, A; Luo, J; Sun, Y; Tsuji, T; Yasuda, H | 1 |
| Detrenis, S; Meschi, M; Savazzi, G | 1 |
| Hook, JB; Ishmael, J; Lock, EA | 1 |
| Oehme, FW; Savides, MC | 1 |
| al-Khalil, I; Douidar, SM; Habersang, RW | 1 |
| Elías, MM; Girardi, G | 1 |
| Jones, AF; Vale, JA | 1 |
| Lisa Catón, V; Monzón Marín, JL; Ochoa Gómez, FJ; Saralegui Reta, I | 1 |
| Jalali, Z; Sheikh-Hamad, D; Timmins, K | 1 |
| Hagiwara, K; Horikawa, S; Ishizuka, S; Nagashima, Y; Nihei, H; Numata, M; Ozasa, H; Sone, M; Yano, T | 1 |
| Carbonell, LF; Cartagena, J; Fenoy, FJ; López Conesa, E; Parrilla, P; Quesada, T; Ramírez, P; Salom, MG | 1 |
| Anand, R; Fernando, B; Goodier, D; Harry, D; Holt, S; Marley, R; Moore, K | 1 |
| Ammenti, A; Ferrante, R; Spagna, A | 1 |
| D'Souza, RJ; Eastwood, JB; Kilner, RG; MacPhee, IA; Oliveira, DB; Turner, DR | 1 |
| Rizzato, G | 1 |
| Itoh, M; Matsumura, Y; Ohkita, M; Shibata, A; Takaoka, M | 1 |
| Arregui, B; Conesa, EL; Fenoy, FJ; López, B; Nadal, JC; Salom, MG; Valero, F | 1 |
| Thomsen, HS | 1 |
| Briguori, C; Colombo, A; Elia, PP; Golia, B; Lepore, S; Librera, M; Manganelli, F; Ricciardelli, B; Riviezzo, G; Scarpato, P; Villari, B | 1 |
| Highet, RJ; Hill, BA; Jones, TW; Lau, SS; Monks, TJ | 1 |
| Davenport, A; Finn, R | 1 |
91 review(s) available for acetylcysteine and Acute Kidney Failure
| Article | Year |
|---|---|
N-Acetylcysteine's Renoprotective Effect in Cardiac Surgery: A Systematic Review and Meta-Analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Cardiac Surgical Procedures; Female; Humans; Male; Odds Ratio; Treatment Outcome | 2022 |
Meta-analytic Techniques to Assess the Association Between N-acetylcysteine and Acute Kidney Injury After Contrast Administration: A Systematic Review and Meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Humans; Publication Bias; Renal Dialysis; Renal Replacement Therapy | 2022 |
Efficacy and safety of N-acetylcysteine for preventing post-intravenous contrast acute kidney injury in patients with kidney impairment: a systematic review and meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Humans; Kidney; Renal Replacement Therapy | 2023 |
Preventing a nonexistent entity: the curious case of contrast and acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Fluid Therapy; Humans; Osmolar Concentration | 2020 |
A Practical Approach to Preventing Renal Complications in the Catheterization Laboratory.
Topics: Acetylcysteine; Acute Kidney Injury; Case-Control Studies; Catheterization; Contrast Media; Coronary Angiography; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney; Laboratories; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Risk Factors; Risk Reduction Behavior; Rosuvastatin Calcium | 2020 |
Current comments on contrast media administration in patients with renal insufficiency.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Humans; Kidney Diseases; Renal Insufficiency; Sodium Bicarbonate | 2021 |
Latest Clinical Evidence About Effect of Acetylcysteine on Preventing Contrast-Induced Nephropathy in Patients Undergoing Angiography: A Meta-Analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Creatinine; Humans; Kidney; Kidney Diseases | 2021 |
Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.
Topics: Acetylcysteine; Acute Kidney Injury; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Renal Dialysis; ST Elevation Myocardial Infarction | 2020 |
Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Drug Therapy, Combination; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Network Meta-Analysis; Prostaglandins; Randomized Controlled Trials as Topic; Sodium Bicarbonate; Vitamins | 2018 |
Vitamins for Prevention of Contrast-induced Acute Kidney Injury: A Systematic Review and Trial Sequential Analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Ascorbic Acid; Contrast Media; Humans; Incidence; Sodium Chloride; Vitamin E | 2018 |
Contrast-induced Nephropathy: Essentials and Concerns.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Contrast Media; Creatinine; Humans; Randomized Controlled Trials as Topic; Sodium Chloride | 2018 |
[Acute Kidney Injury, AKI - Update 2018].
Topics: Acetylcysteine; Acute Kidney Injury; Atherosclerosis; Clinical Trials as Topic; Contrast Media; Hematopoietic Stem Cell Transplantation; Humans; Multicenter Studies as Topic; Sodium Bicarbonate; Sodium Chloride; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
Pharmacological and non-surgical renal protective strategies for cardiac surgery patients undergoing cardiopulmonary bypass: a systematic review.
Topics: Acetylcysteine; Acute Kidney Injury; Anesthetics; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Free Radical Scavengers; Humans; Ischemic Preconditioning; Male; Postoperative Complications; Protective Agents; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Risk Factors; Volatilization | 2019 |
N-Acetylcysteine for Preventing of Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery: A Metaanalysis.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Anti-Inflammatory Agents; Antioxidants; Cardiac Surgical Procedures; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Postoperative Complications; Renal Insufficiency, Chronic; Renal Replacement Therapy | 2018 |
Preconditioning against renal ischaemia reperfusion injury: the failure to translate to the clinic.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Chelating Agents; Disease Models, Animal; Diuretics, Osmotic; Endpoint Determination; Free Radical Scavengers; Humans; Hypoxia-Inducible Factor 1; Ischemic Preconditioning; Kidney; Mannitol; Oligopeptides; Reperfusion Injury; Reproducibility of Results; Translational Research, Biomedical | 2019 |
A Bayesian network meta-analysis of preventive strategies for contrast-induced nephropathy after cardiac catheterization.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Bayes Theorem; Cardiac Catheterization; Contrast Media; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Network Meta-Analysis; Protective Factors; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Risk Factors; Sodium Bicarbonate | 2019 |
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Angiography; Contrast Media; Free Radical Scavengers; Humans; Randomized Controlled Trials as Topic; Research Design; Sodium Bicarbonate | 2013 |
[Severe toxic acute liver failure: etiology and treatment].
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Anti-Infective Agents; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Cholestasis; Combined Modality Therapy; Diagnosis, Differential; Disease Management; Hepatic Encephalopathy; Hepatitis, Viral, Human; Humans; Illicit Drugs; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Mushroom Poisoning; Neurologic Examination; Occupational Diseases; Respiratory Insufficiency; Sepsis; Shock; Time Factors; Valproic Acid | 2013 |
Therapeutic strategies to prevent contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Calcium Channel Blockers; Contrast Media; Diuretics; Dopamine; Fenoldopam; Fluid Therapy; Furosemide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Treatment Outcome; Vasodilator Agents | 2013 |
Contrast-induced acute kidney injury: potential new strategies.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Creatinine; Dopamine; Fluid Therapy; Humans | 2015 |
The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Fluid Therapy; Free Radical Scavengers; Humans; Osmolar Concentration; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency; Sodium Bicarbonate | 2015 |
Bridging Translation by Improving Preclinical Study Design in AKI.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Erythropoietin; Free Radical Scavengers; Humans; Research Design; Sodium Bicarbonate; Translational Research, Biomedical | 2015 |
Remote Ischemic Preconditioning and Contrast-Induced Nephropathy: A Systematic Review.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Contrast Media; Fluid Therapy; Humans; Ischemic Preconditioning; Kidney Tubular Necrosis, Acute; Regional Blood Flow; Risk Factors; Tourniquets; Treatment Outcome; Upper Extremity | 2016 |
Warfarin related nephropathy: a case report and review of the literature.
Topics: Acetylcysteine; Acute Kidney Injury; Anticoagulants; Atrial Fibrillation; Female; Free Radical Scavengers; Heart Valve Prosthesis; Humans; Middle Aged; Warfarin; Withholding Treatment | 2016 |
Acute Kidney Injury Prevention.
Topics: Acetylcysteine; Acute Kidney Injury; Clinical Trials as Topic; Contrast Media; Heart-Assist Devices; Humans; Risk Assessment; Transcatheter Aortic Valve Replacement | 2016 |
N-Acetyl Cysteine Therapy Does Not Prevent Renal Failure in High-Risk Patients Undergoing Open-Heart Surgery.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Female; Free Radical Scavengers; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Postoperative Complications; Prevalence; Randomized Controlled Trials as Topic; Renal Agents; Risk Factors; Survival Rate; Treatment Failure; Treatment Outcome | 2016 |
The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: A systematic review and trial sequential analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Free Radical Scavengers; Humans; Incidence; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Impact of antioxidant supplementations on cardio-renal protection in cardiac surgery: an updated and comprehensive meta-analysis and systematic review.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Ascorbic Acid; Atrial Fibrillation; Cardiac Surgical Procedures; Dietary Supplements; Fatty Acids, Unsaturated; Humans; Incidence; Odds Ratio; Risk Factors; Treatment Outcome | 2016 |
The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sodium Bicarbonate; Treatment Outcome | 2016 |
Prevention of Contrast-Induced Acute Kidney Injury: an Update.
Topics: Acetylcysteine; Acute Kidney Injury; Aminophylline; Animals; Ascorbic Acid; Contrast Media; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Purinergic P1 Receptor Agonists; Theophylline | 2016 |
Efficacy of N-Acetylcysteine in Preventing Acute Kidney Injury After Cardiac Surgery: A Meta-Analysis Study.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Surgical Procedures; Creatinine; Elective Surgical Procedures; Free Radical Scavengers; Hospital Mortality; Humans; Perioperative Care; Postoperative Complications; Treatment Outcome | 2018 |
Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Cardiovascular Surgical Procedures; Creatinine; Humans; Kidney; Postoperative Complications; Randomized Controlled Trials as Topic | 2009 |
Prevention of acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Allopurinol; Aminoglycosides; Amphotericin B; Antifungal Agents; Contrast Media; Dehydration; Dopamine Agonists; Glomerular Filtration Rate; Humans; Hypovolemia; Natriuretic Peptides; Renal Agents; Renal Circulation; Sodium Potassium Chloride Symporter Inhibitors; Theophylline | 2008 |
N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiovascular Surgical Procedures; Confidence Intervals; Education, Medical, Continuing; Female; Hospital Mortality; Humans; Length of Stay; Male; Odds Ratio; Postoperative Complications; Premedication; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Survival Analysis; Treatment Failure | 2009 |
Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Clinical Protocols; Contrast Media; Creatinine; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Medicine; Practice Guidelines as Topic; Radiography, Interventional; Risk Assessment; Specialization; Tomography, X-Ray Computed | 2009 |
[Contrast induced nephropathy].
Topics: Acetylcysteine; Acute Kidney Injury; Algorithms; Contrast Media; Creatinine; Critical Care; Fluid Therapy; Glomerular Filtration Rate; Hospital Mortality; Humans; Kidney Failure, Chronic; Osmolar Concentration; Renal Dialysis; Risk Factors; Sodium Bicarbonate; Theophylline | 2009 |
Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Antioxidants; Female; Humans; Male; Perioperative Care; Randomized Controlled Trials as Topic; Risk Factors; Thoracic Surgical Procedures; Treatment Outcome | 2009 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Fenoldopam; Humans; Renal Dialysis; Renal Insufficiency; Renal Replacement Therapy | 2008 |
Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Biomarkers; Contrast Media; Creatinine; Drug Therapy, Combination; Evidence-Based Medicine; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Sodium Bicarbonate; Treatment Outcome | 2009 |
Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Bicarbonates; Buffers; Cell Hypoxia; Contrast Media; Endothelium, Vascular; Free Radical Scavengers; Humans; Oxidative Stress; Reactive Oxygen Species; Risk Factors | 2010 |
Contrast-induced nephropathy in patients undergoing elective and urgent procedures.
Topics: Acetylcysteine; Acute Disease; Acute Kidney Injury; Adenosine; Ascorbic Acid; Contrast Media; Elective Surgical Procedures; Emergency Treatment; Free Radical Scavengers; General Surgery; Glomerular Filtration Rate; Humans; Hydrotherapy; Preoperative Care; Renal Dialysis; Risk Assessment; Sodium Bicarbonate | 2010 |
Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery?
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Benchmarking; Cardiac Surgical Procedures; Drug Administration Schedule; Evidence-Based Medicine; Hospital Mortality; Humans; Length of Stay; Male; Protective Agents; Renal Replacement Therapy; Reoperation; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Contrast-induced acute kidney injury: the at-risk patient and protective measures.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Cardiac Catheterization; Contrast Media; Drug Therapy, Combination; Free Radical Scavengers; Humans; Hydrotherapy; Risk Assessment; Risk Factors; Sodium Bicarbonate | 2010 |
Nephrotoxicity of contrast media and protective effects of acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Clinical Trials as Topic; Contrast Media; Creatinine; Expectorants; Free Radical Scavengers; Humans; Protective Agents; Treatment Outcome | 2011 |
N-acetylcysteine for the prevention of acute kidney injury after cardiac surgery.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Surgical Procedures; Clinical Trials as Topic; Humans; Randomized Controlled Trials as Topic; Risk Factors | 2011 |
Acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Creatinine; Glomerular Filtration Rate; Humans; Renal Dialysis | 2011 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
[Paraquat poisoning. Case report and overview].
Topics: Acetylcysteine; Acute Kidney Injury; Acute Lung Injury; Adult; Antioxidants; Ascorbic Acid; Combined Modality Therapy; Conscious Sedation; Cooperative Behavior; Critical Care; Dose-Response Relationship, Drug; Emergency Medical Services; Esophagoscopy; Esophagus; Gastric Mucosa; Hemofiltration; Herbicides; Humans; Interdisciplinary Communication; Intermittent Positive-Pressure Ventilation; Intestinal Mucosa; Male; Metabolic Clearance Rate; Oxygen Inhalation Therapy; Paraquat; Prognosis; Pulmonary Edema; Suicide, Attempted | 2012 |
The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Creatinine; Humans; Kidney Diseases; Randomized Controlled Trials as Topic | 2013 |
Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Fluid Therapy; Free Radical Scavengers; Humans; Natriuretic Peptide, Brain; Percutaneous Coronary Intervention; Recombinant Proteins | 2013 |
The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Creatinine; Cystatin C; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Randomized Controlled Trials as Topic; Renal Dialysis; Tomography, X-Ray Computed | 2013 |
Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Clinical Trials as Topic; Contrast Media; Humans | 2002 |
Novel approaches to the treatment of acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Atrial Natriuretic Factor; Calcium Channel Blockers; Clinical Trials as Topic; Dopamine Agonists; Endothelin Receptor Antagonists; Glomerular Filtration Rate; Humans; Purinergic P1 Receptor Antagonists; Renal Agents | 2003 |
Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Cysteine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Outcome Assessment, Health Care; Radiography; Randomized Controlled Trials as Topic | 2003 |
Prevention and nondialytic treatment of acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Crush Syndrome; Diuretics; Fluid Therapy; Free Radical Scavengers; Growth Substances; Humans; Kidney Tubular Necrosis, Acute; Mannitol; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Contrast Media; Creatinine; Humans; Randomized Controlled Trials as Topic | 2003 |
Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Cystine; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed | 2004 |
Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Prospective Studies; Randomized Controlled Trials as Topic; Sodium Chloride | 2004 |
Prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Creatinine; Fenoldopam; Hemofiltration; Humans; Renal Dialysis; Ultrafiltration | 2004 |
[Value of N-acetylcysteine to prevent nephrotoxicity from iodinated contrast agents].
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Humans; Iodine Radioisotopes; Risk Factors; Treatment Outcome | 2004 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Calcium Channel Blockers; Diuretics; Dopamine; Dopamine Agonists; Fenoldopam; Fluid Therapy; Humans; Mannitol; Renal Replacement Therapy; Theophylline | 2003 |
Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiovascular Surgical Procedures; Contrast Media; Coronary Angiography; Humans | 2004 |
Recent advances in the prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Bicarbonates; Clinical Trials as Topic; Contrast Media; Hemofiltration; Humans; Isotonic Solutions; Kidney Failure, Chronic; Radiography; Renal Circulation | 2004 |
Prevention of contrast nephropathy in critically ill patients using acetylcysteine and theophylline.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Critical Illness; Emergency Medical Services; Humans; Phosphodiesterase Inhibitors; Theophylline | 2004 |
Prevention of acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Diuretics; Dopamine Agents; Drug-Related Side Effects and Adverse Reactions; Fluid Therapy; Humans; Natriuretic Peptides; Theophylline | 2005 |
N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Female; Follow-Up Studies; Humans; Kidney Function Tests; Male; Primary Prevention; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed | 2005 |
Future strategies in the treatment of acute renal failure: growth factors, stem cells, and other novel therapies.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Atrial Natriuretic Factor; Disease Models, Animal; Heme Oxygenase-1; Hepatocyte Growth Factor; Humans; Nitric Oxide Synthase; PPAR alpha; Pyrimidines; Stem Cell Transplantation | 2005 |
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atrial Natriuretic Factor; Contrast Media; Diuretics; Endothelins; Epoprostenol; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Iodine Radioisotopes; Kidney Tubules; Models, Biological; Renal Dialysis; Risk Factors | 2005 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Calcium Channel Blockers; Diuretics, Osmotic; Dopamine; Fenoldopam; Fluid Therapy; Humans; Mannitol; Natriuretic Peptides; Renal Dialysis; Renal Replacement Therapy; Sodium Potassium Chloride Symporter Inhibitors; Theophylline | 2005 |
Strategies to prevent contrast nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Ascorbic Acid; Contrast Media; Humans; Phosphodiesterase Inhibitors; Prostaglandins; Theophylline | 2005 |
Management of acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Combined Modality Therapy; Creatinine; Female; Humans; Kidney Function Tests; Male; Prognosis; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome | 2005 |
[Nephropathy caused by radiocontrast media].
Topics: Acetylcysteine; Acute Kidney Injury; Clinical Trials as Topic; Contrast Media; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Isotonic Solutions; Kidney Tubules; Radiopharmaceuticals | 2005 |
Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Controlled Clinical Trials as Topic; Female; Humans; Male; Premedication; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Treatment Outcome | 2006 |
[Contrast nephropathy and heavy metal nephrotoxicity].
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Contrast Media; Endothelins; Heavy Metal Poisoning; Humans; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species; Renal Circulation | 2006 |
Acute renal failure due to phenazopyridine (Pyridium) overdose: case report and review of the literature.
Topics: Acetylcysteine; Acute Kidney Injury; Adolescent; Carnitine; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Methemoglobinemia; Phenazopyridine; Sodium Bicarbonate; Suicide, Attempted; Treatment Outcome | 2006 |
Renal failure (acute).
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Aminophylline; Amphotericin B; Calcium Channel Blockers; Diuretics, Osmotic; Dopamine; Fenoldopam; Fluid Therapy; Humans; Mannitol; Natriuretic Peptides; Renal Dialysis; Renal Replacement Therapy; Theophylline | 2006 |
Prevention of acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Diuretics; Fluid Therapy; Glomerular Filtration Rate; Humans; Natriuretic Peptides; Renal Replacement Therapy; Theophylline; Vasodilator Agents | 2007 |
How to protect from contrast media-induced nephropathy?
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Cardiovascular Diseases; Contrast Media; Free Radical Scavengers; Humans; Risk Assessment; Risk Factors | 2007 |
Prevention of contrast-induced nephropathy: a critical review.
Topics: Acetylcysteine; Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Contrast Media; Creatinine; Diuretics; Evidence-Based Medicine; Fluid Therapy; Humans; Mannitol; Metformin; Osmolar Concentration; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Risk Factors; Theophylline; Viscosity | 2007 |
[Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Free Radical Scavengers; Humans; Premedication; Prospective Studies; Radiography, Interventional; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Preventing contrast medium-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Risk Factors; Vasodilator Agents | 2007 |
[Iodinated contrast agent-induced nephropathy].
Topics: Acetylcysteine; Acute Kidney Injury; Age Factors; Angiography; Clinical Trials as Topic; Contrast Media; Diabetes Complications; Free Radical Scavengers; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Renal Replacement Therapy; Risk Factors; Theophylline; Tomography, X-Ray Computed; Vasodilator Agents | 2007 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Fenoldopam; Free Radical Scavengers; Heart Failure; Humans; Iatrogenic Disease; Kidney Diseases; Kidney Transplantation; Multivariate Analysis; Osmolar Concentration; Phosphodiesterase Inhibitors; Prognosis; Renal Dialysis; Risk Factors; Theophylline | 2008 |
N-acetylcysteine in the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Free Radical Scavengers; Humans | 2008 |
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Ascorbic Acid; Bicarbonates; Clinical Trials as Topic; Contrast Media; Furosemide; Protective Agents; Research Design; Theophylline | 2008 |
Can we prevent acute kidney injury?
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Antifungal Agents; Chemistry, Pharmaceutical; Contrast Media; Critical Care; Dehydration; Free Radical Scavengers; Humans; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors | 2008 |
[Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines].
Topics: Acetylcysteine; Acute Kidney Injury; Age Factors; Aged; Contrast Media; Creatinine; Critical Care; Diabetes Complications; Glomerular Filtration Rate; Hemofiltration; Humans; Italy; Kidney Diseases; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors | 2008 |
Paracetamol poisoning and the kidney.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Chemical and Drug Induced Liver Injury; Drug Overdose; Humans; Kidney | 1993 |
Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Antineoplastic Agents; Cisplatin; Drug Overdose; Female; Free Radical Scavengers; Humans; Kidney; Medication Errors; Time Factors | 1997 |
Novel approaches to the treatment of acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Dopamine Agonists; Endothelin Receptor Antagonists; Growth Substances; Humans; Natriuretic Agents; Renal Agents | 2000 |
60 trial(s) available for acetylcysteine and Acute Kidney Failure
| Article | Year |
|---|---|
Dynamic thiol-disulphide homeostasis as a biomarker for predicting the development of contrast medium-associated acute kidney injury in the endovascular treatment of peripheral arterial disease: should intravenous N-acetylcysteine be given before the proc
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Biomarkers; Contrast Media; Disulfides; Homeostasis; Humans; Peripheral Arterial Disease; Serum Albumin; Sulfhydryl Compounds | 2023 |
Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study.
Topics: Acetylcysteine; Acute Kidney Injury; Allopurinol; Chemoprevention; Contrast Media; Diabetic Nephropathies; Drug Therapy, Combination; Humans; Kidney Failure, Chronic; Linagliptin; Prospective Studies; Protective Agents; Renal Insufficiency, Chronic; Saline Solution | 2023 |
Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.
Topics: Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Administration, Oral; Aged; Angiography; Biomarkers; Contrast Media; Cytokines; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Prognosis; Sodium Bicarbonate | 2020 |
Evaluation the Effects of Alpha-tocopherol in Comparison with N-acetylcystein for Prevention of Contrast Induced Nephropathy (CIN) in CKD Patients.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; alpha-Tocopherol; Contrast Media; Coronary Angiography; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Sodium Chloride | 2020 |
Effect of N-acetylcysteine against Vancomycin-Induced Nephrotoxicity: A Randomized Controlled Clinical Trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Antioxidants; Blood Urea Nitrogen; Creatinine; Female; Humans; Male; Middle Aged; Reactive Oxygen Species; Vancomycin | 2020 |
Double-blind placebo-controlled randomized trial of N-acetylcysteine infusion following live donor liver transplantation.
Topics: Acetylcysteine; Acute Kidney Injury; Double-Blind Method; Humans; Liver Transplantation; Living Donors | 2020 |
The effect of N-acetyl cysteine injection on renal function after coronary artery bypass graft surgery: a randomized double blind clinical trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Antioxidants; Coronary Artery Bypass; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Kidney Function Tests; Male; Middle Aged; Perioperative Care; Postoperative Complications; Treatment Outcome | 2021 |
The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Ascorbic Acid; Blood Urea Nitrogen; Contrast Media; Creatinine; Critical Care; Female; Greece; Humans; Intensive Care Units; Kidney; Male; Middle Aged; Multivariate Analysis; Prospective Studies; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed | 2017 |
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Angiography; Contrast Media; Creatinine; Double-Blind Method; Female; Fluid Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome | 2018 |
N-acetylcysteine decreases urinary level of neutrophil gelatinase-associated lipocalin in deceased-donor renal transplant recipients: a randomized clinical trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Biomarkers; Delayed Graft Function; Double-Blind Method; Female; Free Radical Scavengers; Humans; Kidney Transplantation; Lipocalin-2; Male; Middle Aged; Tissue Donors | 2018 |
Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Diabetic Angiopathies; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Placebos; Risk Factors; Treatment Failure | 2013 |
N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Contrast Media; Emergency Medical Services; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Single-Blind Method; Tomography, X-Ray Computed | 2013 |
Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Aged; Ascorbic Acid; Cardiac Catheterization; Contrast Media; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Incidence; Kidney; Male; Prospective Studies; Treatment Outcome; Urea | 2013 |
High dose of N-acetylcystein prevents acute kidney injury in chronic kidney disease patients undergoing myocardial revascularization.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Cardiopulmonary Bypass; Confidence Intervals; Coronary Artery Bypass; Coronary Stenosis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospital Mortality; Humans; Kidney Failure, Chronic; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Pulse Therapy, Drug; Radiography; Reference Values; Risk Assessment; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2014 |
Addition of N-acetyl cysteine to carvedilol decreases the incidence of acute renal injury after cardiac surgery.
Topics: Acetylcysteine; Acute Kidney Injury; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbazoles; Cardiac Surgical Procedures; Carvedilol; Creatinine; Double-Blind Method; Female; Humans; Incidence; Male; Metoprolol; Middle Aged; Propanolamines; Prospective Studies; Time Factors; Treatment Outcome; Turkey | 2014 |
A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Abdominal Pain; Acetylcysteine; Acute Kidney Injury; Adult; Allografts; Antioxidants; Double-Blind Method; Drug Eruptions; Dyspnea; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Pruritus; Transplantation Conditioning; Vasodilator Agents; Young Adult | 2015 |
Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Cardiac Catheterization; Clinical Protocols; Contrast Media; Coronary Angiography; Diuresis; Diuretics; Double-Blind Method; Drug Administration Schedule; Fluid Therapy; Furosemide; Heart Valve Prosthesis Implantation; Humans; Infusions, Intravenous; Israel; Research Design; Sodium Chloride; Time Factors; Treatment Outcome; Urinary Catheterization | 2014 |
Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Contrast Media; Coronary Angiography; Female; Humans; Iothalamic Acid; Male; Middle Aged; Osmolar Concentration; Sodium Bicarbonate | 2014 |
Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Antioxidants; Biomarkers; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Creatinine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Perioperative Care; Republic of Korea; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Water-Electrolyte Balance | 2015 |
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary Angiography; Cystatin C; Cytoprotection; Diabetic Nephropathies; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Female; Humans; Infusions, Intravenous; Iohexol; Israel; Lipocalin-2; Male; Middle Aged; Prospective Studies; Protective Agents; Recombinant Proteins; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2016 |
Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Treatment Outcome | 2016 |
N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Critical Illness; Deferoxamine; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Hypotension; Incidence; Intensive Care Units; Male; Middle Aged | 2016 |
Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Cardiovascular Diseases; Creatinine; Double-Blind Method; Female; Humans; Male; Perioperative Care; Treatment Outcome | 2008 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Heart Diseases; Humans; Iohexol; Italy; Myocardial Infarction; Prospective Studies; Research Design; Single-Blind Method; Syndrome; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2010 |
Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Renal Insufficiency, Chronic; Risk Factors | 2010 |
N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Creatinine; Double-Blind Method; Female; Free Radical Scavengers; Glomerular Filtration Rate; Glutathione; Graft Survival; Humans; Incidence; Kaplan-Meier Estimate; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Reperfusion Injury; Risk Factors; Treatment Outcome | 2010 |
Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Atorvastatin; Contrast Media; Coronary Angiography; Creatinine; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles | 2010 |
Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Creatinine; Female; Free Radical Scavengers; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Prospective Studies; Single-Blind Method; Treatment Outcome | 2010 |
N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Humans; Male; Middle Aged; Oxidative Stress; Treatment Outcome | 2010 |
N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children: translational pharmacokinetics.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Adolescent; Analgesics, Non-Narcotic; Animals; Antineoplastic Agents, Alkylating; Area Under Curve; Child; Drug Overdose; Female; Humans; Ifosfamide; Male; Protective Agents; Rats; Rats, Wistar | 2012 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Dehydration; Female; Fluid Therapy; Free Radical Scavengers; Humans; Kidney; Male; Middle Aged; Prospective Studies | 2011 |
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Carbonates; Contrast Media; Female; Fluid Therapy; Furosemide; Humans; Male; Renal Insufficiency; Risk Factors; Sodium Chloride | 2011 |
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: a randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Antioxidants; Critical Illness; Deferoxamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypotension; Interleukin-6; Male; Middle Aged; Nitrites; Oxidative Stress; Siderophores | 2012 |
Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Double-Blind Method; Female; Free Radical Scavengers; Humans; Iohexol; Kidney Failure, Chronic; Male; Treatment Outcome; Vitamin E | 2012 |
Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Contrast Media; Creatinine; Drug Therapy, Combination; Female; Fluid Therapy; Free Radical Scavengers; Humans; Male; Middle Aged; Prospective Studies | 2013 |
N-acethyl-cysteine reduces the occurrence of contrast-induced acute kidney injury in patients with renal dysfunction: a single-center randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Contrast Media; Creatinine; Female; Humans; Male; Middle Aged; Plasma Substitutes; Renal Insufficiency; Sodium Bicarbonate; Sodium Chloride; Triiodobenzoic Acids | 2013 |
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Animals; Atorvastatin; Cells, Cultured; Contrast Media; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; JNK Mitogen-Activated Protein Kinases; Male; Middle Aged; Pyrroles; Tumor Suppressor Protein p53 | 2012 |
A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Incidence; Male; Middle Aged; Prospective Studies | 2002 |
Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Recovery of Function; Triiodobenzoic Acids | 2003 |
Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Free Radical Scavengers; Humans; Iohexol; Male; Prospective Studies; Statistics, Nonparametric; Treatment Outcome | 2003 |
Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Prospective Studies; Randomized Controlled Trials as Topic; Sodium Chloride | 2004 |
Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Cardiovascular Diseases; Comorbidity; Contrast Media; Coronary Angiography; Creatinine; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Insufficiency; Urea | 2004 |
[Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Ioxaglic Acid; Kidney Failure, Chronic; Male; Prospective Studies; Treatment Failure | 2003 |
Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Male; Malondialdehyde; Oxidative Stress; Pilot Projects; Probability; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Single-Blind Method | 2005 |
Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiography; Antioxidants; Contrast Media; Creatinine; Double-Blind Method; Female; Humans; Infusions, Intravenous; Iohexol; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Treatment Outcome | 2004 |
Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Aortic Aneurysm; Double-Blind Method; Female; Free Radical Scavengers; Humans; Ischemia; Male; Middle Aged; Placebos; Treatment Outcome | 2006 |
N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial.
Topics: Acetylcysteine; Acetylglucosaminidase; Acute Kidney Injury; Aged; Albuminuria; Aorta, Abdominal; Creatinine; Cystatin C; Cystatins; Double-Blind Method; Female; Humans; Infusions, Intravenous; Kidney Glomerulus; Kidney Tubules; Male; Postoperative Complications | 2006 |
N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Creatinine; Female; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction | 2006 |
Prevention of contrast agent-induced renal impairment in patients with chronic renal insufficiency and heart disease by high-dose intravenous N-acetylcysteine: a pilot-ministudy.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Creatinine; Heart Diseases; Humans; Infusions, Intravenous; Pilot Projects; Poland; Premedication; Renal Insufficiency, Chronic; Safety; Treatment Outcome | 2006 |
Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
Topics: Acetylcysteine; Acetylglucosaminidase; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Creatinine; Cystatin C; Cystatins; Double-Blind Method; Female; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Male; Middle Aged; Postoperative Complications; Preanesthetic Medication; Prospective Studies; Treatment Failure; Water-Electrolyte Balance | 2006 |
Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aortic Aneurysm, Abdominal; Biomarkers; Contrast Media; Creatinine; Free Radical Scavengers; Humans; Intraoperative Complications; Male; Pilot Projects; Prospective Studies; Research Design; Retinol-Binding Proteins; Serum Albumin; Stents; Time Factors; Treatment Failure; Vascular Surgical Procedures | 2006 |
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Diuresis; Diuretics; Female; Fluid Therapy; Follow-Up Studies; Free Radical Scavengers; Germany; Humans; Isotonic Solutions; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Survival Analysis | 2007 |
N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON).
Topics: Acetylcysteine; Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Free Radical Scavengers; Humans; Hypotension; Intensive Care Units; Male; Middle Aged; Prospective Studies; Time Factors | 2007 |
Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Blood Pressure; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Creatinine; Female; Free Radical Scavengers; Humans; Kidney; Lactic Acid; Male; Premedication; Preoperative Care; Treatment Outcome | 2007 |
Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Contrast Media; Coronary Stenosis; Creatinine; Female; Fluid Therapy; Follow-Up Studies; Humans; Kidney Function Tests; Logistic Models; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Radiography; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2008 |
I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Biomarkers; Contrast Media; Creatinine; Cystatin C; Cystatins; Emergency Medical Services; Female; Humans; Injections, Intravenous; Iohexol; Male; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Creatinine; Female; Free Radical Scavengers; Heart Diseases; Humans; Length of Stay; Male; Prospective Studies; Renal Insufficiency, Chronic; Renal Replacement Therapy; Treatment Outcome | 2008 |
Acetylcysteine and contrast agent-associated nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Biomarkers; Coloring Agents; Contrast Media; Creatinine; Female; Free Radical Scavengers; Glutathione; Humans; Male; Middle Aged; Research Design; Vasodilation | 2002 |
144 other study(ies) available for acetylcysteine and Acute Kidney Failure
| Article | Year |
|---|---|
Renoprotective effect of N-acetylcysteine depends upon the severity of the ischemia reperfusion injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Humans; Kidney; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury | 2021 |
An Activatable Near-Infrared Fluorescence Probe for in Vivo Imaging of Acute Kidney Injury by Targeting Phosphatidylserine and Caspase-3.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Apoptosis; Biomarkers; Caspase 3; Cell Line; Cisplatin; Coordination Complexes; Female; Fluorescent Dyes; Indoles; Infrared Rays; Mice, Inbred BALB C; Mice, Nude; Optical Imaging; Phosphatidylserines; Zinc | 2021 |
Contrast Induced Acute Kidney Injury (CI- AKI) - Myths and Realities.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Humans; Renal Dialysis; Risk Factors | 2021 |
CHIPS: Prevention of contrast-induced nephropathy before and after cardiac catheterization.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Hemofiltration; Humans | 2021 |
Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Drug Delivery Systems; Female; Gold; HEK293 Cells; Humans; Kidney; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2021 |
Ifosfamide-induced acute kidney injury in a patient with leiomyosarcoma: A case report.
Topics: Acetylcysteine; Acute Kidney Injury; Creatinine; Female; Humans; Ifosfamide; Leiomyosarcoma; Mesna; Urea | 2022 |
Beyond the
Topics: Acetylcysteine; Acute Kidney Injury; Humans; Kidney | 2023 |
Acute kidney injury after treatment of paracetamol overdose using new N-acetylcysteine guideline.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Analgesics, Non-Narcotic; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Humans | 2023 |
Investigating the Possible Protective Role of Direct Intra-arterial Administration of Mannitol and N-Acetylcysteine and Per Os Administration of Simvastatin Against Contrast-Induced Nephropathy: An Experimental Study in a Rabbit Model.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Animals; Contrast Media; Disease Models, Animal; Diuretics, Osmotic; Humans; Infusions, Intra-Arterial; Iohexol; Male; Mannitol; Rabbits; Simvastatin | 2019 |
The effect of N-acetylcysteine on inflammation and oxidative stress in cisplatin-induced nephrotoxicity: a rat model
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Cisplatin; Creatinine; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Treatment Outcome | 2019 |
Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Saline Solution; Sodium Bicarbonate; United States; Veterans Health Services | 2020 |
Protective Effect of N-Acetylcysteine Pretreatment on Acute Kidney Injury in Septic Rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cecum; Disease Models, Animal; Kidney; Ligation; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Sepsis | 2020 |
The potential protective role of folic acid against acetaminophen-induced hepatotoxicity and nephrotoxicity in rats.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Folic Acid; Free Radical Scavengers; Oxidative Stress; Rats, Sprague-Dawley | 2021 |
Systemic inflammation and oxidative stress contribute to acute kidney injury after transcatheter aortic valve implantation.
Topics: Acetylcysteine; Acute Kidney Injury; Aortic Valve; Aortic Valve Stenosis; Biomarkers; C-Reactive Protein; Humans; Inflammation; Interleukin-6; Oxidative Stress; Peroxidase; Transcatheter Aortic Valve Replacement; Treatment Outcome; Tumor Necrosis Factor-alpha | 2022 |
Evaluation of coenzyme Q10 combined with or without N-acetyl cysteine or atorvastatin for preventing contrast-induced kidney injury in diabetic rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Atorvastatin; Contrast Media; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Drug Therapy, Combination; Male; Rats; Rats, Sprague-Dawley; Ubiquinone | 2021 |
Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Dose-Response Relationship, Drug; Male; Piperazines; Proto-Oncogene Proteins p21(ras); Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |
PICK1 Deficiency Exacerbates Sepsis-Associated Acute Kidney Injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Apoptosis; Carrier Proteins; Cell Cycle Proteins; Cell Line; Disease Models, Animal; Epithelial Cells; Humans; Kidney Tubules, Proximal; Lipopolysaccharides; Male; MAP Kinase Kinase Kinase 5; Mice, Inbred C57BL; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Peroxides; Sepsis | 2021 |
Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Carbolines; Cell Death; Cell Line; Cyclohexylamines; Deferoxamine; Dose-Response Relationship, Drug; Ferric Compounds; Glutathione; Heme Oxygenase-1; Iron Chelating Agents; Kidney Tubules, Proximal; Membrane Proteins; Mice, Knockout; Phenylenediamines; Piperazines; Quaternary Ammonium Compounds; Signal Transduction; Time Factors | 2018 |
The role of oxidative stress in acute renal injury of newborn rats exposed to hypoxia and endotoxin.
Topics: Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Animals; Animals, Newborn; Antioxidants; Biomarkers; Blood Urea Nitrogen; Cell Adhesion Molecules; Disease Models, Animal; Gene Expression; Humans; Hypoxia; Infant; Lipocalin-2; Lipocalins; Lipopolysaccharides; Oxidative Stress; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins; Rats; Reactive Oxygen Species | 2017 |
Acute kidney injury: Preventing angiography-associated kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Humans; Kidney; Sodium Bicarbonate | 2018 |
Acute kidney injury: Antioxidants do not PRESERVE kidney function after contrast exposure.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Angiography; Contrast Media; Creatinine; Double-Blind Method; Female; Fluid Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome | 2018 |
N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Cell Proliferation; Disease Models, Animal; Disease Progression; Energy Metabolism; Kidney; Male; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; Mitochondria; NAD; Oxidative Stress; Phosphorylation; PPAR gamma; Renal Insufficiency, Chronic; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2018 |
Connexin32 plays a crucial role in ROS-mediated endoplasmic reticulum stress apoptosis signaling pathway in ischemia reperfusion-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Apoptosis; Connexins; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Epithelial Cells; Gap Junction beta-1 Protein; Gene Deletion; Gene Knockout Techniques; Kidney; Male; Mice, Inbred C57BL; Phenylbutyrates; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Taurochenodeoxycholic Acid | 2018 |
PRESERVE: The End or the Beginning of a New Era in Prevention of Contrast-Associated Acute Kidney Injury?
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Humans; Sodium Bicarbonate | 2018 |
Lessons learned from the PRESERVE trial.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Administration, Oral; Angiography; Contrast Media; Female; Free Radical Scavengers; Humans; Male; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Research Design; Sodium Bicarbonate | 2018 |
N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions.
Topics: Acetylcysteine; Acetylglucosaminidase; Acute Kidney Injury; Animals; Colistin; Creatinine; Disease Models, Animal; Free Radical Scavengers; Humans; Kidney; Male; Matrix Metalloproteinase 3; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2018 |
Role of Some Natural Antioxidants in the Modulation of Some Proteins Expressions against Sodium Fluoride-Induced Renal Injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Benzoquinones; Glutathione; Kidney; Male; Oxidative Stress; Rats; Rats, Wistar; Sodium Fluoride | 2018 |
Lessons learnt from managing a case of dengue hemorrhagic fever complicated with acute liver failure and acute kidney injury: a case report.
Topics: Acetylcysteine; Acidosis, Lactic; Acute Kidney Injury; Adult; Antioxidants; Diabetes Mellitus, Type 2; Erythrocyte Transfusion; Female; Fluid Therapy; Humans; Liver Failure, Acute; Renal Replacement Therapy; Severe Dengue | 2018 |
Protective effects of N-acetyl-cysteine in mitochondria bioenergetics, oxidative stress, dynamics and S-glutathionylation alterations in acute kidney damage induced by folic acid.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Disease Models, Animal; Energy Metabolism; Folic Acid; Glutathione; Humans; Mitochondria; Mitochondrial Dynamics; Oxidative Stress; Protein Processing, Post-Translational; Rats | 2019 |
N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Cellular Senescence; Cisplatin; Fibrosis; Humans; Kidney; Mice; Oxidative Stress; Rats; Renal Insufficiency, Chronic; Sirtuin 1; Tumor Suppressor Protein p53 | 2019 |
Effects of hydrogen sulfide on acetaminophen-induced acute renal toxicity in rats.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Analgesics, Non-Narcotic; Animals; Apoptosis; Cell Adhesion Molecules; Free Radical Scavengers; Hydrogen Sulfide; Kidney Tubules; Lipocalin-2; Lipocalins; Male; Oxidative Stress; Proto-Oncogene Proteins; Rats; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2019 |
N-Acetylcysteine (NAC) for the Prevention of Liver Failure in Heat Injury-Mediated Ischemic Hepatitis.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Consciousness Disorders; Free Radical Scavengers; Heat Stress Disorders; Hot Temperature; Humans; Liver Failure; Male; Prospective Studies; Rhabdomyolysis | 2019 |
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Apoptosis; Cisplatin; Complement C5a; Disease Models, Animal; Inflammation; Kidney; Male; Mice; Mice, Inbred C57BL; Neutrophils; Oxidative Stress; Receptor, Anaphylatoxin C5a | 2019 |
N-acetyl-l-cysteine exacerbates kidney dysfunction caused by a chronic high-sodium diet in renal ischemia and reperfusion rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Blood Pressure; Brain Ischemia; Free Radical Scavengers; Ischemia; Kidney; Male; Rats; Rats, Wistar; Reperfusion; Reperfusion Injury; Sodium Chloride, Dietary | 2019 |
[Prevention of "contrast-induced" acute kidney injury - practical considerations].
Topics: Acetylcysteine; Acute Kidney Injury; Clinical Trials as Topic; Contrast Media; Epidemiologic Studies; Humans; Tomography, X-Ray Computed | 2019 |
Ameliorative effects of N-acetyl cysteine on diclofenac-induced renal injury in male rats based on serum biochemical parameters, oxidative biomarkers, and histopathological study.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Biomarkers; Creatinine; Diclofenac; Humans; Kidney; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Uric Acid | 2019 |
Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Biomarkers; Cardiology; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Sodium Bicarbonate; Sodium Chloride; Time Factors; Treatment Outcome | 2013 |
The effects of N-acetylcysteine and ozone therapy on oxidative stress and inflammation in acetaminophen-induced nephrotoxicity model.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Analgesics, Non-Narcotic; Animals; Drug Evaluation, Preclinical; Free Radical Scavengers; Kidney; Male; Nephritis; Oxidative Stress; Ozone; Random Allocation; Rats; Rats, Sprague-Dawley | 2013 |
N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Creatinine; Deferoxamine; Erythrocytes; Male; Nephrectomy; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Urine; Warfarin | 2013 |
The relationship between N-acetylcysteine, hyperbaric oxygen, and inflammation in a rat model of acetaminophen-induced nephrotoxicity.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Creatinine; Free Radical Scavengers; Hyperbaric Oxygenation; Inflammation; Interleukin-6; Male; Neopterin; Oxygen; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Urea | 2013 |
Antioxidant treatment and outcome of Cortinarius orellanus poisoning: a case series.
Topics: Acetylcysteine; Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Cortinarius; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Mushroom Poisoning; Renal Insufficiency, Chronic | 2013 |
N-acetylcysteine in contrast-induced acute kidney injury: clinical use against principles of evidence-based clinical medicine!
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Evidence-Based Medicine; Humans; Kidney; Treatment Outcome | 2014 |
Preconditioning renoprotective effect of isoflurane in a rat model of virtual renal transplant.
Topics: Acetylcysteine; Acute Kidney Injury; Anesthetics, Inhalation; Animals; Free Radical Scavengers; Ischemic Preconditioning; Isoflurane; Kidney; Kidney Transplantation; Models, Animal; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |
DNA damage response in renal ischemia-reperfusion and ATP-depletion injury of renal tubular cells.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine Triphosphate; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Checkpoint Kinase 2; DNA Damage; Glucose; Histones; Kidney; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reperfusion; Reperfusion Injury; Tumor Suppressor Protein p53 | 2014 |
Protective effect of N-acetylcysteine (NAC) on renal ischemia/reperfusion injury through Nrf2 signaling pathway.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Free Radical Scavengers; Male; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Treatment Outcome | 2014 |
Carfilzomib-related acute kidney injury may be prevented by N-acetyl-L-cysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Antineoplastic Agents; Humans; Male; Oligopeptides | 2015 |
Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker.
Topics: Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Contrast Media; Disease Models, Animal; Diuretics; Free Radical Scavengers; Furosemide; Iohexol; Ioxaglic Acid; Kidney; Lipocalin-2; Lipocalins; Magnetic Resonance Imaging; Male; Oxygen; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Triiodobenzoic Acids | 2014 |
Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-κB) signaling pathway.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Survival; Cyclooxygenase 2; Dinoprostone; I-kappa B Kinase; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mesangial Cells; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Rats; Sepsis; Signal Transduction; Thioctic Acid; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2015 |
Effects of dexpanthenol and N-acetylcysteine pretreatment in rats before renal ischemia/reperfusion injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Drug Evaluation, Preclinical; Free Radical Scavengers; Kidney; Male; Pantothenic Acid; Random Allocation; Rats, Wistar; Reperfusion Injury | 2014 |
SUMOylation occurs in acute kidney injury and plays a cytoprotective role.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Free Radical Scavengers; HEK293 Cells; Humans; Kidney Tubules, Proximal; Mice; Oxidative Stress; Rats; Salicylates; SUMO-1 Protein; Sumoylation; Tumor Suppressor Protein p53 | 2015 |
Sulfasalazine-induced renal injury in rats and the protective role of thiol-reductants.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antirheumatic Agents; Dithiothreitol; Drug Evaluation, Preclinical; Free Radical Scavengers; Male; Random Allocation; Rats, Sprague-Dawley; Sulfasalazine | 2016 |
The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Antidotes; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Half-Life; Hemofiltration; Humans; Infusions, Intravenous; Prospective Studies; Renal Dialysis; Tissue Distribution | 2015 |
Improving Intravenous Fluid Therapy for Prevention of Contrast-Induced Nephropathy: How to Give More Without Causing Heart Failure.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Creatinine; Fluid Therapy; Heart Failure; Humans; Kidney Diseases | 2016 |
An Effective and Safe Hydration Method for the Prevention of Contrast-Induced Nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Fluid Therapy; Humans; Kidney Diseases | 2016 |
N-acetylcysteine in Cleistanthus collinus Poisoning: A Report of Two Cases in Children.
Topics: Acetylcysteine; Acute Kidney Injury; Child; Glycosides; Humans; Hydrogen-Ion Concentration; Hypokalemia; Kidney Tubules; Male; Plant Extracts; Plant Poisoning; Suicide, Attempted; Treatment Outcome; Vomiting | 2016 |
N-acetylcysteine reduces the renal oxidative stress and apoptosis induced by hemorrhagic shock.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Biomarkers; Combined Modality Therapy; Fluid Therapy; Male; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Resuscitation; Shock, Hemorrhagic; Treatment Outcome | 2016 |
Incidence and characterization of acute kidney injury after acetaminophen overdose.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Adult; Analgesics, Non-Narcotic; Biomarkers; Creatinine; Drug Overdose; Female; Humans; Incidence; Intensive Care Units; Liver Diseases; Male; Middle Aged; Retrospective Studies | 2016 |
N-acetylcysteine protects against star fruit-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Averrhoa; Creatinine; Fruit; Glomerular Filtration Rate; Hyperoxaluria; Kidney; Male; Oxalates; Oxidative Stress; Protective Agents; Rats; Rats, Wistar | 2017 |
Nephroprotective Effects of N-Acetylcysteine Amide against Contrast-Induced Nephropathy through Upregulating Thioredoxin-1, Inhibiting ASK1/p38MAPK Pathway, and Suppressing Oxidative Stress and Apoptosis in Rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Apoptosis; Contrast Media; Kidney; Male; MAP Kinase Kinase Kinase 5; Microscopy, Electron, Transmission; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protective Agents; Rats; Rats, Sprague-Dawley; Signal Transduction; Superoxide Dismutase; Thioredoxins; Up-Regulation | 2016 |
Heat stroke leading to acute liver injury & failure: A case series from the Acute Liver Failure Study Group.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Female; Heat Stroke; Humans; Liver; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Prospective Studies; Registries; Renal Replacement Therapy; Rhabdomyolysis; United States | 2017 |
Protective effects of N-acetylcystein and atorvastatin against renal and hepatic injury in a rat model of intestinal ischemia-reperfusion.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Atorvastatin; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestines; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Protective Agents; Rats; Rats, Wistar; Reperfusion Injury | 2017 |
Protective effects of N-acetylcysteine on cyclosporine-A-induced nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Analysis of Variance; Animals; Biopsy, Needle; Blood Urea Nitrogen; Creatinine; Cyclosporine; Disease Models, Animal; Immunohistochemistry; Kidney; Male; Malondialdehyde; Microscopy; Nitric Oxide; Probability; Random Allocation; Rats; Rats, Wistar | 2008 |
Comparative protective effect of N-acetyl cysteine and tetramethylpyrazine in rats with gentamicin nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Body Weight; Creatinine; Gentamicins; Kidney Cortex; Male; Protective Agents; Protein Synthesis Inhibitors; Pyrazines; Rats; Rats, Wistar; Urea; Urodynamics | 2009 |
Factors associated with the use of preventive care for contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Angiography; Clinical Competence; Contrast Media; Data Collection; Female; Glomerular Filtration Rate; Hospitals, Veterans; Humans; Iatrogenic Disease; Internship and Residency; Isotonic Solutions; Male; Middle Aged; Odds Ratio; Prospective Studies; Tomography, X-Ray Computed | 2009 |
Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Deferoxamine; Drug Therapy, Combination; Free Radical Scavengers; Gentamicins; Male; Rats; Rats, Wistar; Siderophores | 2009 |
Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antineoplastic Agents; Capillary Permeability; Cisplatin; Glutathione; Inflammation Mediators; Kidney; Kidney Function Tests; Mice; Mice, Inbred ICR; Mice, Knockout; NF-E2-Related Factor 2; Oligonucleotide Array Sequence Analysis; Reperfusion Injury; Up-Regulation | 2009 |
Renal insufficiency after cardiac surgery: a challenging clinical problem.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Surgical Procedures; Creatinine; Humans; Risk Factors | 2009 |
In search of an algorithm to prevent acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Algorithms; Clinical Protocols; Contrast Media; Drug Therapy, Combination; Evidence-Based Medicine; Free Radical Scavengers; Humans; Kidney Diseases; Practice Guidelines as Topic; Risk Assessment; Sodium Bicarbonate; Treatment Outcome | 2009 |
Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Free Radical Scavengers; Humans; Myocardial Infarction; Oxidative Stress | 2010 |
Comparison of the effects of N-acetyl cysteine and erdosteine in rats with renal injury caused by paracetamol intoxication.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Data Interpretation, Statistical; Female; Kidney; Kidney Function Tests; Radionuclide Imaging; Rats; Rats, Wistar; Thioglycolates; Thiophenes | 2011 |
Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Female; Free Radical Scavengers; Humans; Italy; Male; Middle Aged; Retrospective Studies; Sodium Chloride; Treatment Outcome | 2011 |
Evaluation of efficacy of vitamin E and N-acetyl cysteine in gentamicin-induced nephrotoxicity in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Anti-Bacterial Agents; Antioxidants; Drug Evaluation, Preclinical; Gentamicins; Male; Rats; Rats, Sprague-Dawley; Vitamin E | 2011 |
Are we still wondering or wandering in the dark?
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Female; Free Radical Scavengers; Humans; Male; Sodium Chloride | 2011 |
Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antineoplastic Agents; Antioxidants; Biomarkers; Cisplatin; Drug Administration Schedule; Female; Kidney; Kidney Function Tests; Lipid Peroxidation; Rats; Rats, Sprague-Dawley; Taurine | 2011 |
Protective effect of beta-glucan on contrast induced-nephropathy and a comparison of beta-glucan with nebivolol and N-acetylcysteine in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Benzopyrans; beta-Glucans; Blood Urea Nitrogen; Contrast Media; Creatinine; Ethanolamines; Female; Nebivolol; Protective Agents; Rats | 2011 |
Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Azoles; Drug Evaluation, Preclinical; Drug Therapy, Combination; Free Radical Scavengers; Isoindoles; Male; Organoselenium Compounds; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2011 |
N-acetylcysteine is effective for prevention but not for treatment of folic acid-induced acute kidney injury in mice.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Animals, Outbred Strains; Creatinine; Cystatin C; Folic Acid; Glutathione; Kidney Function Tests; Male; Mice; Survival Analysis | 2011 |
N-acetylcysteine (NAC) protects against acute kidney injury (AKI) following prolonged pneumoperitoneum in the rat.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Carbon Dioxide; Glomerular Filtration Rate; Infusions, Parenteral; Inulin; Kidney; Male; Models, Animal; Oxidative Stress; Pneumoperitoneum; Rats; Rats, Wistar; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Time Factors | 2012 |
Minimizing the renal toxicity of iodinated contrast.
Topics: Acetylcysteine; Acute Kidney Injury; Carbonates; Contrast Media; Coronary Angiography; Female; Furosemide; Humans; Male; Sodium Chloride | 2011 |
Hemolysis and hemolytic uremic syndrome following five-fold N-acetylcysteine overdose.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Adult; Female; Hemolysis; Hemolytic-Uremic Syndrome; Humans; Medication Errors; Poisoning; Treatment Outcome; Young Adult | 2011 |
Commentary on "N-acetylcysteine (NAC) protects against acute kidney injury following prolonged pneumoperitoneum".
Topics: Acetylcysteine; Acute Kidney Injury; Humans; Pneumoperitoneum; Protective Agents | 2011 |
N-acetylcysteine and acute renal failure: are we doing too little too late?
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Male | 2011 |
N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Cecum; Disease Models, Animal; Glomerular Filtration Rate; Kidney; Lung; Male; Neutrophils; Oxidative Stress; Pulmonary Edema; Rats; Rats, Wistar; Respiration, Artificial; Sepsis; Sodium Channels; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2 | 2012 |
Pretreatment with pentoxifylline and N-acetylcysteine in liver ischemia reperfusion-induced renal injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Free Radical Scavengers; Liver; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Outcome | 2012 |
Protective effects of N-acetylcysteine amide (NACA) on gentamicin-induced apoptosis in LLC-PK1 cells.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Survival; Cells, Cultured; Disease Models, Animal; DNA; Flow Cytometry; Free Radical Scavengers; Gene Expression Regulation; Gentamicins; LLC-PK1 Cells; NF-kappa B; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Swine | 2012 |
Effect of N-acetylcysteine (NAC) on acute lung injury and acute kidney injury in hemorrhagic shock.
Topics: Acetylcysteine; Acute Kidney Injury; Acute Lung Injury; Animals; Arterial Pressure; Glucose; I-kappa B Proteins; Interleukin-6; Male; Malondialdehyde; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrates; Nitrites; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic | 2013 |
Protective effect of N-acetylcysteine on kidney as a remote organ after skeletal muscle ischemia-reperfusion.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Creatinine; Ischemia; Male; Muscle, Skeletal; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury | 2012 |
Role of nitric oxide metabolites in reduction of sodium potassium ATPase dependent pulmonary edema clearance.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Male; Pulmonary Edema; Respiration, Artificial; Sepsis | 2012 |
[Presentation of a case of Paraquat poisoning].
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Ascorbic Acid; Charcoal; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diuretics; Fatal Outcome; Furosemide; Gastric Lavage; Hemoperfusion; Humans; Immunosuppressive Agents; Male; Paraquat; Poisoning; Pulmonary Fibrosis; Respiration, Artificial; Respiratory Insufficiency; Rhabdomyolysis; Suicide, Attempted; Vitamin E | 2012 |
Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury?
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Intravenous; Anaphylaxis; Contrast Media; Humans; Practice Guidelines as Topic; Risk Assessment | 2012 |
Protective effects of alpha lipoic acid versus N-acetylcysteine on ifosfamide-induced nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Glutathione; Ifosfamide; Kidney; Lipid Peroxidation; Male; Nitric Oxide; Oxidative Stress; Rats; Thioctic Acid | 2015 |
N-acetylcysteine as salvage therapy in cisplatin nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Humans; Middle Aged; Salvage Therapy | 2002 |
[Paracetamol nephropathy].
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Apoptosis; Cells, Cultured; Humans; Kidney Tubules | 2002 |
Effects of N-acetylcysteine on myoglobinuric-acute renal failure in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Cryoprotective Agents; Disease Models, Animal; Free Radical Scavengers; Glycerol; Hypertonic Solutions; Injections, Intraperitoneal; Kidney; Myoglobinuria; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors | 2002 |
Protection from contrast-induced nephropathy: is the answer in?
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Triiodobenzoic Acids | 2003 |
N-acetylcysteine ameliorates renal microcirculation: studies in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Dinoprostone; Enzyme Inhibitors; Hypoxia; Kidney Cortex; Kidney Diseases; Kidney Medulla; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation | 2003 |
A randomized trial of prophylactic acetylcysteine and theophylline compared with placebo for the prevention of renal tubular vacuolization in rats after iohexol administration.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Free Radical Scavengers; Iohexol; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Theophylline; Vacuoles; Vasodilator Agents | 2003 |
Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Analysis of Variance; Case-Control Studies; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kidney Function Tests; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Radiopharmaceuticals; Reference Values; Treatment Outcome | 2003 |
A drug to prevent renal failure?
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Cysteine; Humans; Kidney Failure, Chronic; Meta-Analysis as Topic; Terminology as Topic | 2003 |
Role of acetylcysteine in the prevention of contrast-media-induced nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Antidotes; Cardiac Catheterization; Contrast Media; Creatinine; Databases, Factual; Endpoint Determination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2003 |
N-acetylcysteine to prevent contrast nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Angina Pectoris; Cardiac Catheterization; Contrast Media; Coronary Angiography; Humans; Kidney Failure, Chronic; Male | 2004 |
Treatment of intoxication with Cortinarius speciosissimus using an antioxidant therapy.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Antioxidants; Female; Humans; Male; Mushroom Poisoning; Selenium | 2004 |
Effectiveness of acetylcysteine on preventing renal dysfunction in patients undergoing coronary procedures.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Case-Control Studies; Coronary Angiography; Female; Humans; Male; Statistics, Nonparametric; Treatment Outcome | 2004 |
Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Contrast Media; Female; Humans; Incidence; Kidney; Kidney Function Tests; Male; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, X-Ray Computed | 2004 |
Prevention of acute renal failure with N-acetylcysteine--enough is enough?
Topics: Acetylcysteine; Acute Kidney Injury; Humans | 2004 |
Effect of N-acetylcysteine on antioxidant status in glycerol-induced acute renal failure in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Analysis of Variance; Animals; Disease Models, Animal; Female; Glycerol; Kidney Function Tests; Male; Oxidative Stress; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity | 2004 |
Acute renal dysfunction in acetaminophen poisoning.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Adult; Age Distribution; Aged; Drug Overdose; Emergency Treatment; Female; Follow-Up Studies; Humans; Incidence; Kidney Function Tests; Male; Middle Aged; New York City; Risk Assessment; Severity of Illness Index; Sex Distribution; Treatment Outcome | 2005 |
Renal protection by radical scavenging in cardiac surgery patients.
Topics: Acetylcysteine; Acute Disease; Acute Kidney Injury; Aged; Cardiopulmonary Bypass; Cardiovascular Surgical Procedures; Coronary Vessels; Creatinine; Female; Free Radical Scavengers; Humans; Male; Randomized Controlled Trials as Topic; Retrospective Studies | 2005 |
Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Blood Flow Velocity; Cell Membrane; Dietary Supplements; Disease Models, Animal; Glomerular Filtration Rate; Ischemia; Kidney; Magnesium Chloride; Male; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Renal Circulation | 2005 |
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Female; Fluid Therapy; Humans; Iohexol; Kidney; Male; Middle Aged; Osmolar Concentration; Renal Insufficiency, Chronic; Retrospective Studies; Triiodobenzoic Acids | 2005 |
N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion.
Topics: Acetylcysteine; Acute Kidney Injury; Analysis of Variance; Animals; Biopsy, Needle; Creatinine; Disease Models, Animal; Glomerular Filtration Rate; Glutathione; Immunohistochemistry; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reference Values; Renal Circulation; Reperfusion Injury; Statistics, Nonparametric | 2006 |
Effects of N-acetylcysteine on radiocontrast nephropathy in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Female; Glomerular Filtration Rate; Kidney Function Tests; Kidney Tubules; Probability; Radiopharmaceuticals; Random Allocation; Rats; Rats, Wistar; Reference Values; Risk Factors; Sensitivity and Specificity | 2006 |
Preplaced cell division: a critical mechanism of autoprotection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death in mice.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antimitotic Agents; Blood Urea Nitrogen; Cell Division; Colchicine; Creatinine; Cyclin-Dependent Kinases; DNA; Dose-Response Relationship, Drug; G1 Phase; Kidney; Male; Mice; Phosphoprotein Phosphatases; Protein Phosphatase 1; S Phase; Signal Transduction; Time Factors | 2006 |
Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antimitotic Agents; Calcium-Binding Proteins; Calpain; Colchicine; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Kidney Function Tests; Kidney Tubules, Proximal; Longevity; Male; Mice; Regeneration | 2006 |
Contrast-induced nephropathy: pharmacological prophylaxis.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Ascorbic Acid; Calcium Channel Blockers; Contrast Media; Dopamine; Humans; Kidney; Kidney Diseases; Randomized Controlled Trials as Topic; Vasoconstriction | 2006 |
N-acetylcysteine and contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Contrast Media; Dose-Response Relationship, Drug; Hospital Mortality; Humans; Kidney Diseases; Myocardial Infarction | 2006 |
Renal protection by N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Research Design | 2007 |
Sic transit acetylcysteine?
Topics: Acetylcysteine; Acute Kidney Injury; Humans | 2007 |
N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model.
Topics: Acetylcysteine; Acute Kidney Injury; Analysis of Variance; Animals; Cardiopulmonary Bypass; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation Mediators; Kidney Function Tests; Male; Oxidative Stress; Postoperative Complications; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Factors; Sensitivity and Specificity | 2007 |
N-Acetylcysteine for the prevention of renal dysfunction in high-risk patients undergoing coronary bypass graft surgery: an unfulfilled promise?
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Surgical Procedures; Free Radical Scavengers; Humans; Kidney; Treatment Outcome | 2007 |
Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aging; Child; Chronic Disease; Contrast Media; Drug Interactions; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Hypoglycemic Agents; Kidney Diseases; Metformin; Renal Dialysis; Risk Assessment | 2007 |
N-acetylcysteine as a preventive measure for acute renal failure: a plea for more accurate detection of renal function in critically ill patients.
Topics: Acetylcysteine; Acute Kidney Injury; Critical Illness; Free Radical Scavengers; Humans; Hypotension; Intensive Care Units; Kidney Function Tests; Time Factors | 2007 |
Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Surgical Procedures; Evidence-Based Medicine; Humans; Kidney Failure, Chronic; Research Design | 2007 |
[Use of N-acetylcysteine prior to cardiac catheterization to prevent acute renal injury in patients with stage III chronic kidney disease].
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Cardiac Catheterization; Contrast Media; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies | 2007 |
N-acetylcysteine: multiple organ saver during cardiac surgery?
Topics: Acetylcysteine; Acute Kidney Injury; Free Radical Scavengers; Heart Diseases; Humans; Research Design; Treatment Outcome | 2008 |
Multimodality prevention of contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Ascorbic Acid; Biomarkers; Cell Death; Cell Hypoxia; Consensus; Contrast Media; Creatinine; Epithelial Cells; Fluid Therapy; Humans; Inflammation; Infusions, Intravenous; Kidney Tubules; Multicenter Studies as Topic; Oxidative Stress; Practice Guidelines as Topic; Protective Agents; Randomized Controlled Trials as Topic; Renal Circulation; Treatment Outcome | 2008 |
Of hypes and hopes: N-acetylcysteine and cystatin C.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Contrast Media; Cystatin C; Cystatins; Free Radical Scavengers; Humans; Tomography, X-Ray Computed | 2008 |
The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antineoplastic Agents; Antioxidants; Cisplatin; Cross-Linking Reagents; Disease Models, Animal; Free Radical Scavengers; Male; Melatonin; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Proline; Rats; Rats, Sprague-Dawley; Thiocarbamates; Tumor Necrosis Factor-alpha | 2008 |
Nephrotoxicity of hexachloro-1,3-butadiene in the mouse: the effect of age, sex, strain, monooxygenase modifiers, and the role of glutathione.
Topics: Acetylcysteine; Acute Kidney Injury; Aging; Animals; Butadienes; Female; Glutathione; Kidney Tubular Necrosis, Acute; Lethal Dose 50; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; p-Aminohippuric Acid; Sex Factors; Species Specificity; Tetraethylammonium; Tetraethylammonium Compounds; Urea | 1984 |
Acetaminophen and its toxicity.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Animals; Cats; Chemical and Drug Induced Liver Injury; Cricetinae; Dogs; Ethanol; Glutathione; Guinea Pigs; Humans; Kinetics; Liver; Mice; Rats | 1983 |
Severe hepatotoxicity, acute renal failure, and pancytopenia in a young child after repeated acetaminophen overdosing.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Chemical and Drug Induced Liver Injury; Child, Preschool; Drug Overdose; Female; Humans; Pancytopenia; Peritoneal Dialysis | 1994 |
Effect of different renal glutathione levels on renal mercury disposition and excretion in the rat.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Blood Urea Nitrogen; Glutathione; Kidney; Male; Maleates; Mercuric Chloride; Rats; Rats, Wistar | 1993 |
[Carbon tetrachloride poisoning].
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Free Radical Scavengers; Humans; Male; Middle Aged; Occupational Diseases | 1996 |
Regulation and immunohistochemical analysis of stress protein heme oxygenase-1 in rat kidney with myoglobinuric acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Enzyme Induction; Glutathione; Glycerol; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Immunohistochemistry; Injections, Intramuscular; Kidney; Male; Myoglobinuria; Rats; Rats, Wistar; Stress, Physiological | 1997 |
Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion.
Topics: Acetylcholine; Acetylcysteine; Acute Kidney Injury; Animals; Constriction; Dogs; Enzyme Inhibitors; Female; Free Radical Scavengers; Injections, Intra-Arterial; Ischemia; Kidney; Male; NG-Nitroarginine Methyl Ester; Renal Circulation; Reperfusion; Vena Cava, Inferior | 1998 |
Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane A2 receptor.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Carbazoles; Cholestasis; Dinoprost; Glutathione; Ligands; Lipid Peroxidation; Male; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Sodium; Sulfonamides; Thioctic Acid; Thromboxane B2 | 1999 |
Renal impairment without hepatic damage after acetaminophen overdose.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Adolescent; Charcoal; Drug Overdose; Female; Humans; Kidney; Liver; Treatment Outcome | 1999 |
Acute renal failure from intoxication by Cortinarius orellanus: recovery using anti-oxidant therapy and steroids.
Topics: Acetylcysteine; Acute Kidney Injury; Adrenal Cortex Hormones; Agaricales; Aged; Antioxidants; Female; Humans; Mushroom Poisoning | 1999 |
[Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Free Radical Scavengers; Humans; Iodine; Kidney Failure, Chronic; Randomized Controlled Trials as Topic | 2001 |
Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Blood Urea Nitrogen; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Endothelin-1; Ischemia; Kidney; Male; Multienzyme Complexes; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Renal Circulation; Reperfusion Injury | 2001 |
N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Blood Flow Velocity; Disease Models, Animal; Enzyme Inhibitors; Free Radical Scavengers; Glomerular Filtration Rate; Kidney Medulla; Laser-Doppler Flowmetry; NG-Nitroarginine Methyl Ester; Nitrates; Nitrites; Rats; Rats, Wistar; Regional Blood Flow; Reperfusion; Reperfusion Injury; Vena Cava, Inferior | 2001 |
Contrast-medium-induced nephrotoxicity: are all answers in for acetylcysteine?
Topics: Acetylcysteine; Acute Kidney Injury; Combined Modality Therapy; Contrast Media; Double-Blind Method; Fluid Therapy; Humans; Iohexol; Premedication; Randomized Controlled Trials as Topic; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Differences in the localization and extent of the renal proximal tubular necrosis caused by mercapturic acid and glutathione conjugates of 1,4-naphthoquinone and menadione.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Blood Urea Nitrogen; Glutathione; Kidney Cortex; Kidney Medulla; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Magnetic Resonance Spectroscopy; Male; Naphthoquinones; Rats; Rats, Inbred Strains; Vitamin K | 1990 |
Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma.
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Adult; Female; Hepatic Encephalopathy; Humans; Kidney Tubular Necrosis, Acute; Male | 1988 |